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CORRELATED INCIDENCES OF SOME COMPLICATIONS OF PORTAL CIRRHOSIS 
-Adapted from Bel1(9). 
Degree of number of 'of cases %of oases in bber of oases number of oases 
hemosiderosis oases in males age g.roup 60+ of diabetes of melanoderma 
0 5o1 66% 29% 48 ? 
1- 32 69 28 0 0 a-
1 77 73 42 6 0 
2 66 79 53 7 0 
3 48 87.5 48 18 18 
Key: 
Grade 3 hemosiderosis- Hemosiderin abundant in every lobule and frequently in the portal tracts. 
II 2 II - MOderate amounts of hemosiderin in most lobules. 
II 1 II - Most lobiles free of hemosiderin• Moderate amounts in a few lobules. 
II 1- II ~ Minimal amounts of hemosiderin in occasional lobules. 
7 
Bell ~i:~ Eot :i.~'lcln ....... e ·l·~::~r, -: r·1cl·· ·' ·····-cp. ,..._., , c·· - · · 
- · ~ -~ '· c • ·: c l ~ ,J L -._:C.:OcJ'l .. ')..·.·c._ C 
f-."'~,-ilf.~Y''lt "'l, ..... -i,,-~111 
•• ..t. -J ·-'---~- '---'·- ·--' ·'-'_"j in 
8i~~l1:~.fj_ CRl1C 8 of \ ., r; L' ••.• •> 
'
8. ... _:.:'I __ T.., 7-, i <: ·. ~-· ~ -~.!..--. 8 -:~ ·-_-. ·~ ~_,~J .. c~_o. -.·.·_ -~l, 11 0 -p 'r . ..., -~ 1:1·' r-- ., '0-") -'- ,..-,' 
- ._ ···- ·- - - '""- _, ._,. - ..L. -'- (__.. ~---~- (.."" • ._ ,_.:' j_·· J.. V•.l...i .. 
t~·JO 
i11.c~LclerJ.CO o::~ 
be C<J-_11"1 G 
be. 
iron overlJ 
rrhe of il1.-~~o~_-,s st in 
of 
·;- J_ ., uo ;_,{l 
J. -:::; :r· -,>'"). J '-'-./ 
o.n. 
"'·- t 
r• -1- ·• '- -~ - --- ,.., ·•· l 
~:J..J .l..J..:..~k.l.JJ.VI..v_ 
·'· v to 
-, r:'' 
.c.u 
8 _1_·_8~C '-...... .l-'-' ~- -. l.J 
t:.:c 
0 
u 
paper, hm·rever, is Hi th the :metabolism of iron overload-l1.o~-r it 
comes about, ho~-r it is han~ned by t}J.e bo~~y ~'.ncl ~Jl'lat its ei'fec ts are 
on the tissues. 
9 
I- ?rotein~irin Connls~ss 
to 5 
O.J..-P -·.~··'·-1- 0·--· --~-.2"0~·~- ~ _ .. - .... c ... · -· .. ' 1 , l d __ . _ ~' _ ..L.:..· . .-:_J_:;_ c; :-; ln ·c,:.e o_ oo , 
Iron. :c. 
:. l 
::· ~ __ ., - sed :fro: 1 
' > • --•. -~ '. ·' • 
. _.;·- '·- ·.- of 
- .. 
c)_:_ ·';c·:.l.J. .. _, :t. 
-.v .J.·: 
1 ;ls. 
_·_e 
n.::/c 
J.O 
--,1 -_ ::J:-J.a . -
'"' 
, ..-. -- ..., I 
-"~... ..... _. ___ :_ 
.l'OD. i . .l.. .... :) o' 
·::. '~ 
- ~:'Lc J. 
~");:: l (':e (l 'l '-) 
- ..•.• ' .!. -- • 
A. 0Gl' _'Ill Iron 
·_c_,_Q_ "i_t"':C" .• l.J_--_-L"' ''-- 'l-'- ,.~-"' c;" r.,···o ---~ _ -,~='-_jl.IJ uJ. \~,\_;,~_,, __ • 
:'.OJ.l~. Cz?.11 
c :i. t - of -:~:--:.e ··• ~;P''.ln. 
,." r.-:"l \ .-.-";1~-, -, 
·'· .V...l. ·../,_.:.;·'- '·- ;:1.-- 1· C :· lLi.-
:t ::; l. <1 ·~ then pas ;:;ed OV3I' 
resin, only t:1.at anJ.ou11t of iron in e::·;:cess of tl-:e iron bin·:~:'Ln:::; 
capac:i_ty ·.-rill disa:_;rear from the:; ;:eru:.1(13). Lo~ever, if super-
saturated serun is dialyseQ asainst saline, ~~ere will be only 
a very slight shift of iron into the saline. . .. . ' ln:.:_~_CEt --ce S that 
t~1e e:;;:cess iron c~:oes not e:dst in sel'lE1 tmbo11nd. It Ls rather 
loosely and non-spec:i.ficly bound to other plasna p:c'oteins, 
especially alb-u:eJ.in(l5). 
11 
..., 
which the rate iron enters and the rate iron leaves the senmm are equal. • 
It is elevated when the rate of hemolysis exceeds the rate at which iron 
is incorporated into new red cells(hemolytic anemia, pernicious anemia, 
aplastic anemia); when increased amounts of iron enter the serum, as in 
oral or parenteral iron therepy; in acute hepatitis(perhaps due to the 
release of liver ferritin into the circulation(l6)); and in hemochromatosis. 
In idiopathic hemochromatosis the serum mron is usually elevated to the 
point of 100% saturation of the serum iron binding capacity. The serum 
iron concentration is lower than normal in conditions of increased 
erythropoesis such as polycythemia and in anemia in remission; in iron 
deficiency anemia; and in infections, malignancy following surgery and in 
other conditions of stress(ll). 
The half-life of serum iron is a way of expressing the rate 
at which a given amount of iron will disappear from the serum. Normally 
it is around 100 minutes(6). The serum iron half-life is prolonged when 
tissue demands for iron decrease, as in aplastic anemia. It is also 
prolonged in hemochromatosis, although the reasons for this prolongation 
are less obvious than in the instance of aplastic anemia(6). In 
conditions of increased tissue demands for iron(polycythemia, iron 
deficienc.y anemia, infection) the half-life of serum iron is shortened(l7). 
B. Intracellular Iron Binding Proteins: Ferritin and Hemosiderin. 
Iron is stored in the tissues as ferritin and hemosiderin. 
~hese substances are increased in a state of iron excess and become 
depleted in iron deficiency. Hemosiderin granules are large enough to 
be visible under the light microscope and they stain with prussian blue 
dye. They are the characteristic granules which can be seen in tissues 
when excess iron is present. Ferritin molocules are submicroscopic in size, 
are normally present in many tissues, and can be isolated from almost any 
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tissue several hours after iren has been introduced into the tissue (12,14). 
1. .Perri tin 
Ferritin was first isolated in 1937 by Laufberger. Since that time 
a great deal has been learned about its structure and functions . 
A variable amouat of Fe is co:atained. in ferritin, usually ranging 
between 17 ani 2~ of' i t1 dry weight. The protein moiety of ferri tia, known 
as apoferritin, has a m.w. ot 46o,ooo. All the iron can be removed from 
ferritin without damagimg the protein (12). 
Initial stuties by Granick (7) an4 by Michaelis (18) suggested that 
clustereeor micelles ot ferric hyroxide-phospbate becaae attached to the surface 
ot an apoferritin aelecule and that a number of these molecules then becaae 
linked together to fora terri tin crystals. Michaelis found that the terri tin 
ions in these micelles contained three unpairea electrons instead of the much 
cODmlOner states ot 1 or 5 unpaired electro:as. The uniqueness of the three un-
paired electron state was circumstantial evidence suggesting the mediation of' 
enzyme activity in the f'Qnaation of. ferric hydroxide micelles. 
More recent work by Mazur (19) and by Farr&l'lt (20) indicates that the 
ferric hydroxide micelles are situated iaside the ferritin molecule rather 
than on the surface. On the basis of' a variety of' evidence it was postulated 
that the bulk of iron iR ferritin is imternally situated and that only a small 
fraction is in ionic f'orll on the surface of the molecule. Farrant suggested 
an equilibri'Uil between the i:nternally situated ancl. surface iron. Aa surface 
"""' ferric ions are recluced ancl removed from the molecule more ferric ions pass from 
the internal micelles to the surface.. 
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Study with the electron microscope indicates that the ferritin molecule 
consists of a core of four closely adjoining, electron dense particles and a 
peripheral shell that is not deRse to electrons. The core particles are probably 
ferric hydroxide-phosphate micelles and the peripheral shell, protein (20). 
Mazur demonstrated. by strictly chemical means that a small amount of 
ferrous ion is present on the surface of ferritin. At the slightly alkaline pH 
of body fluids ferrous ion is ordinarily rapidly oxid.ized to ferric ion. 
Autooxidation is partially prevented on the surface of ferritin because the 
ferrous ions are stabilized through chelation with surface sulfhydryl groups. 
When the sulfhydryl groups are oxidized. to disulfide linkages the ferrous iens 
also are oxidized and they then tend to became attached to iaterD&lly situated 
micelles. Surface ferrous ion, on the other hand, will d.issociate from ferritin 
in the presemce of a suitable iron binding ageJ!J.t. Reducing agents such as 
glutathione and hydrosulfite and conditions of relative hypoxia facilitate 
tae removal 6f iron from ferritin, while oxidizing agents and more aerobic 
conditions contribute to the binding of new iron by ferritin. 
The specific stimulus to ferritin synthesis is iron. When a large 
dose of ferrous sulfate is fed to a guinea pig, the ferritin content of the 
intestinal mucosa increases markedly for several hours and then declines 
slowly over a period of clays. At llO poiJ!J.t, before or after the feeding of 
iron, can a measurable amount of apoferritin be isolated from the guinea pig's 
intestinal •ucosa (21). The failure to isolate apoferritin frgm tissues pra.pted 
the observation by Michaelis ( 18) that "the protein apoferritin appears to be 
synthesized at the moaent when it is to be used f•r the storage of iron". 
Experiments have indicated that the apoferritin molecule is completely synthesized 
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before any iron is incorporated to form ferritin(22). One could postulate 
that iron acts as a catalyst for apoferritin synthesis or that iron 
stabilizes apoferritin once it has been synthesized. The latter possibility 
implies that apoferritin is continually being synthesized and destroyed in 
tissues but remains at undeb•ctable levels until iron is present to convert 
apoferritin to the more stable ferritin, thereby shifting the entire 
reaction in favor of synthesis. 
Ferritin, ~men released into the blood is active as a vasodepressor 
and as an antidiuretic(l2). Its vasodepressent action has been implicated 
in the production ad irreversable shock in some cases of hemochramatosis(23). 
2. Hemosiderin 
The term hemosiderin is a misnomer steming from the time w.hen this 
substance was thought to be a degradation product of hemoglobin. It is now 
known that hemosiderin, like ferritin, is synthesized by tissues in the 
presense of iron overload. But while ferritin can normally be found in 
many tissues, hemosiderin is not a nor.nal constituent of tissues. Its presense 
is pathognomonic of localized or generalized hemosiderosis(l4,24). 
One of the earliest contributions to the biochemistry of hemosiderin 
~~s made by Cook in 1929. He observed that iron can be removed from the 
hemosiderin granule by treatment with acid leaving the substrate practically 
intact. This suggested that hemosiderin consists of an iron compound in 
physical combination with an organic residue. Cock also observed that the 
iron compound contaiDed only the elements Fe, H and o, and that it does not 
behave like ionic iron but reacts with various substances in a manner similar 
to a pure ferric oxide solution. Cook concluded that hemosiderin consists of 
organic granules impregnated with some form of ferric oxide. (25) 
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He was net entirely correct about the cheadcal composition of the iron 
particles, which have since been shown to consist of ferric hydroxide-phosphate 
complexes (one P04 for every nine J'e atoms) siJililar or identical. in chemical 
composition and magnetic properties to the iron micelles of ferritin (26). 
Hemesi4erin granules are, ot ceurse, much larger thaD ferritin aolecules. 
They also may coatain up to 35~ iron by try weight ( 14) , and therefore tlllld to 
have a higher concentration of iron taan does ferritin. 
Gramck ( 7) postulated that helaosiclerin granules are nothing more than 
clumps of ferritin molecules. As the concentration of ferritin in tissue increases, 
ferr~tin molecules might tend to clum.p together into large aggregates, giving 
the microscopic picture of hemosiderin granules. He also postulated that the 
iron micelles were larger in hemosiderin than in ferritin, thereby accounting 
for the clifferent iron concentrations of the two complexes. Recent work w1 th 
the electron microsNpe bas indicated, however, that the micelles in b.eaosiderin 
are of the same or4er of ll&gni tude as in terri tin, but are more closely packed 
together in heaosid.erin, w~ch might account for the greater iroa content (26). 
Richter's recent stud7 of heaosiderin with the electron microscope 
clarities considerably the nature of hemosiderin and its relation to ferritin (26). 
He studied heraosiderin deposits ia rats and in lii&B, relating observations with 
the electron microscope to the picture seen under the ordinary light microscepe. 
Typical iron positive hemosiderin granules were found to contain innumerable 
closely packe4, electron dense particles eabedAed ia matter much less dense to 
~ electrons. Similar particles were often diffusely scattered throughout the 
cytoplasm of cells containing heaosi4erin. Tbese electron dense particles have the 
same appearance under the electron microscope as do the iron micelles of ferritin. 
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The dense aggregates representing hemosiderin granules were often in the 
form of discrete cytoplasmic organelles bordered by membranes to which 
Richter gave the name "siderosomes." The membranous borders were often 
markedly disrupted and many aggregates shewed no surrounding membranes. 
Richter postulated that hemosiderin is synthesized in these organelles, 
which may be derivitives of mitochondria, and that the organelles later 
disrupt resul. ting in the gradual diffasion of particles away from the 
granules 
aggregate. The hemosiderin/seen in the liver cells and renal tubular cells 
of rats contained particles of uniform size with a mean diameter of 55 Angstroms. 
This di~ter is the same as the diameter of the electron dense core of a 
molocule of horse ferritin. Hemosiderin granules seen in sections If 1i ver 
and spleen from a patient with Cooley's Anemia and transfusion hemosiderosis 
did not displ~ the uniformity of particle size seen in rat hemosiderin. 
The diameters of particles, however, tended to vary by intervals of 8 A., 
suggesting that the particles were built up from small, uniform subunits. 
~ I Richter& observations support Granicks original supposition 
that ferritin is a compoD&Dt of hemosiderin. They also offer evidence 
that hemosiderin is synthesized from ferritin within discrete cytoplasmic 
organelles. Disintegration of the organelle is followed by resolution of 
the hemosiderin granule into the componant ferritin molowl.es and dispersion 
of the latter throughout the cytoplasm of the cell • 
.3. Functional lelationships between ferritin and hemosiderin 
The dynamic interrelations between ferritin and hemosiderin have 
been very little studied to date. A few observations have been made, however, 
that deserve mention. 
Nol'Dlal.ly, most of the storage iron in the liver is present in the 
ferritin fraction. In iron overload, however, an increasing proportion 
of the iron is present in the hemosiderin fraction. When a number of 
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rabbits are injedted intravenously with large doses of colloidal iron and 
then killed at various intervals after injection, ranging between 1 month 
and 2 years., it is found that ferritin iron soon reaches a peak con-
centration and after that any increase in liver iron is reflected 
quantitatively by an increase in hemosiderin iron (24). This experiment 
provides the rationale for the observation made by a number of investigators 
that the degree of iron overload in an organ can be estimated with reasonable 
accuracy from histological sections. 
When a trace amount of radioactive iron is injected into an animal and 
the animal is killed a day later and its liver fractionated, it is observed 
that the proportion of total radioactive iron found in the ferritin fraction 
is greater than the pro;ortion of nonradioactive iron in that fraction (24,2!). 
Ferritin, therfore, has a greater predilection for incorporating new iron 
entering the cell than does hemosiderin. This observation is in accord 
with what is known about the structure of these two substances. A given 
weight of ferritin has more surface area than an egual weight of hemosiderin, 
and therfore more receptor sites for incoming iron. In view of Richter's 
observations on the s:rnthesis of hemosiderin, it may well be that all the 
iron entering a cell is first incorporated into ferritin and only later 
rerouted to hemosiderin. 
Initial experiments indicate that after bleeding, iron is mobilized 
equally well from both ferritin and hemosiderin (24). Studies on cases of 
hemochromatosis treated by repeated venesection indicate that storage iron 
is seldom, if ever, inaccessible to mobilization. These patients rarely 
become anemic before their iron stores have been depleted. 
c. Equilibria among iron stores: the labile iron pool. 
While virtually all of the storage iron normally or pathologivally 
present in the body can be mobilized by repeated venesection, only a 
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small part of the storage iron is labile under ordinary conditions. Finch(28) 
has estimated that it takes a year for an injected tracer dose of radioiron 
to equilibrate completely with all the iron in the body. Some storage iron, 
therefore, is labile only to a slight degree. 
It can readily be appreciated that there must also be a very labile 
iron pool in the body which permits the constant recycling of iron from 
sites of red cell destruction back to sites of red cell synthesis. A roughly 
quantitative est~Ate of the size of the labile iron po&l can be obtained by 
some simple mathematical deductions from known facts. Normally about 25 mg. 
of iron are bothl set free from and incorporated into hemoglobin each day. 
Presumably this iron is cycled from sites of red cell catabolism to sites of 
red cell synthesis by way of the circulating serum iron. If a tracer dose of 
siderophilin-bound radioiron is injected intravenously into a nonnal person 
and the radioactivity in his red cells measured daily for two to three vreeks, 
it will be noted, first of all, that almost all the radioiron appears in the 
red cells by the end of the period of study(29) and, secondly, that the 
fraction of the injected dose appearing in the red cells in the first four to 
five days increases by an average increment of 15% per day(30). The first 
observation indicates that there is very little exchange between serum iron 
and the less labile iron stores. The second observation permi»s an estimate 
of the size of the labile iron pool. The fraction of tracer radioiron 
utilized each day will be equal to the total amount of iron utilized divided 
by the total amount of iron in the labile iron poo 1. This latter quantity vrl.ll 
consist of the 25 mg. Fe released each day plus an unknown quantity. That is 
to say: 25 mg. • 0.15 
2$ mg. + X mg. and. X•l42 mg. 
(30) 
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Since the total am::>unt of storage iron in the body is estimated to 
k normally around 1000 to 1500 mg. (31), it can be seen that the 
labile iron pool is very small compared to the amount of less labile 
storage iron. On the other hand, the amount of labile iron is far greater 
than the 3 to 6mg. normally present in the serum. The llbile iron pool 
probably exists primarily within the reticulo-endothelial system (29), 
however, at least in hemosiderosis, it probably does not represent all 
the iron stored within the reticulo-endothelial system. There may be 
labile protein-iron complexes in the tissues which are as yet uncharacterizeed. 
In patients with idiopathic hemochromatosis, red cell utilization 
of intravenous iron is uaually within normal limits despite the increased 
amounts of tissue iron (6) • 
Following oral administration of radioiron, red cell utilization of the 
* absorbed dose is normally from 70-80 % (~3) and is therefore slightly less 
than utilization of intravenously administered iron. Apparently, a small part 
of the absorbed dose is stored in the liver. In hemochromatosis, utilization 
of absorbed iron is markedly depressed: only 10-30% appears in the red 
** cells, the rest going into storage (33,34,35). 
*Estimates of utilization tend to be somewhat low because they depend 
on 100% recovery of unabsorbed iron in the feces. When recovery is less 
than lmo%, and it will always bexslightly less unless stools are collected 
for several weeks, the estimate of absorption is sligttly too high and 
therefore the estimate of utilization too low. This error will be 
greater, the lower the percentage of absorption. In view of this, it is not 
certain that the utilization of absorbed radioiron is less than utilization 
of intravenous radioiron. 
*lfSince the normal life of a :red cell is 125 days (30), the labile iron 
pool would have to be 25 mg. times 125 or 3.125 gms. in size before it 
would be large enough to depress ultimate utilization of a tracer dose of 
radioiron. Therefore, unless the labile pool is greater than 3 gms., the 
amount not utilized approximately represents the amount entering storage 
(this is assuming that red cell radioactivity is measured for a long enough 
period of time). Depressed utilization does not necessarily imply a 
compensatory increase in absorption. to meet boae marrow iron demand. Iron 
utilzed for red cell synthesis may be derived both from absorbed iron and 
from storage iron. Possibly the difference between the developmental phase 
of hemochromatosis when absorption is increased and the late phase wnen 
absorption may be normal (see page31) is that in the former all iron for 
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II IRON ABSORPTION AND EXCRETION 
{)lEI 
In the average daily American or European Ythere are 10-25 mg. of 
iron, 5-10% of which is normally absorbed (29). Daily excretion probably 
approaches the amount absorbed. 
A. Excretion 
It is now almost universally belibed, and, unfortunately, too often 
taken for granted that, in the absence of blood loss or hemoglobinuria, 
iron excretion from the body is negligible and that the iron balance, 
therefore, is entirely determined by intake and absorption. This beliff 
is primarily a consequence of the now classic iron balance studies of 
Widdowson and McCance (4). These investigators determined the iron excretion 
in feces and urine of four young adults before, during and after a permed 
of very high oral intake. They found that, althogh in a six week high intake 
period ( 1 gm of iron per day), positive iron balances of from 2-6 grams 
had been attained, excretion following this period rapidly fell off to 
normal levels and the retained iron was not excreted. In another study 
(36) they gave 100 mg. of iron intravenously over a two week period to 
several subjects. Balance studies showed that the injected iron was 
almost completely retained. Urinary excretion doubled during the period of 
injections but, as normal iron loss in the urine is seldom more than 
0.5 mg. per day, and often less, this could account for only a small 
fraction of the administered iron. 
& 
jjl em synthesis comes from absorbed iron, requiring an increase in 
absorption to compensate for the low utilization, while in the latter, 
red cell iron is derived from both absorption and storage, therfore 
requiring no increase in absorption• 
21 
The conclusion that iron excretion from the body is negligible and can 
therefore be ignored is the result of an incorrect generalization from the 
observations of McCance and Widdowson. These investigators showed only that 
iron excretion in the urine and feces is negligible in respect to abnormally 
high intake and that, therefore, iron excretion is relatively inflexible and 
does not compensate for high intakes. However, under comditions of normal 
intake and absorption and particularly when intake and absorption are less 
than normal, iron excretion~ approach or even exceed absorption and 
negative balances may temporarely or intermittantly result. This is, of 
course, excluding from consideration blood losses due to hemorrhage, menstruation 
or pregnancy which are of recognized significance. Some iron from the sld.nst, 
up to 0.5 JDi• in the urine(4) and probably another 0.5-1.0 mg. in the feces 
are lost :from the body every- day. Normal iron excretion in the bile has been 
reported to be as high as 1.0 mg. per day(29). 
* One avenue of iron excretion which McCance and Widdowson did not take 
into consideration is the skin. Mitchell and Hamilton(37) noted significant 
quantities of iron in sweat. Their claim that up to 6 mg. iron a day can be 
lost through normal sweating is certainly too high. Their finding that 
excessive sweating great~ly increases the amount of irbn lost is of considerable 
interest, however. Adams, Leslie and Lev.i.n(38) found that there are significant 
amounts of iron in desquamated skin but not in sweat as such. Studies with 
radioactive iron have indicated virtually no loss through the skin(6) but the 
use of radioactive iron is ill-sui ted for studies or iron excretion, especially 
excretion through the skin, because of the extremely slow eqtilibration between 
radioactive iron and tissue iron stores. On the other hand, even in ile'iculously 
careful studies of total iron excretion through the skin the possibility of 
external contandnation cannot be ruled out. Iron loss through the skin remains 
one of the imponderables in the eTaluation of iron excretion. 
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3% of the iron derived from red cell breakdown passes into the bile(39). 
In hemolytic anemias this may amount to as much as 6 mg. a day. Wainwright (40) 
has reported that up to 9 mg. of iron daily are excreted into the bile of 
South Africans with severe hemosideresis. Because patients with hemolytic 
anemias don't go into negative iron balance it has been assumed that nearly 
all of the iron excreted in the bile is reabsorbed(29). There is no apparent 
reason why this should be so. It might be more reasonable to assur.1e that 
biliary iron is reabsorbed with more or less the same efficiency as dietary 
iron, but that all the iron in the intestine is absorbed l-rith greater than 
normal efficiency in the presense of some anemias. The increased efficiency 
of iron absorption in hypochromic (33) also explains why iron excretion so 
rarely results in progressively negative iron balance. The important thing 
to be remembered about iron excretion with respect to hemochromatosis and 
hemosiderosis is that excretion does not ordinarely significantly adapt tp 
excessive intake. An interesting case in point is one reported by Widdowson 
and McCance(41). They did balance studies for one month on a woman with a 
sever hemolytic anemia who received two transfusions a week for several 
/\ 
months. This woman's rate of hemolysis was such that she set free 80 mg. of 
iron per day. In spite of this, her excretion of iron in the urine and feces 
was consistently less than her dietary intake. 
B. Absorption 
T~ere is a vast literature on the subject of iron absorption, only 
a small part of which can be touched upon here. For a thorough and critical 
review of this important subject the reader is reffned to tw·o articles by 
Josephs, the more recnt one having been published in the beginning of 1958(29,42). 
1\.._ 
Iron is absorbed primarely in the duodenum and it is absorbed through 
the mucosal cells·into the portal blood stream rather than into the lymphatics(29). 
Physicochar.~cal considerations suggest that iron is probably absorbed in the 
ferrous form. 
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1. Mechanism of absorption: is there a mucosal bloc? 
"' The fact that normally only a small fraction of dietary iron is 
absorbed, together with the fact that the efficiency of absorption 
increases in iron deficiency anemia, suggested to several investigatoes 
that the intestinal mucosa responds in some way to the body's need for 
iron. The only complete theory yet devised to explain how this alteration 
in the efficiency of absorption comes about is the theory of the W'Cosal 
bloc first suggested by Hahn and spelled out more explicitly by Granick(,). 
Granick observed or deduced the following"facts": 
1. that "mucosal cells must provide a one way transfer of ferrous 
ion into these cells." No iron can move from the mucosal cell into the 
gut lumen. Granick reasoned this from the absence of fecal excretion 
of body iron. 
2. that there is a :resisi tence to ieon absorption in normal persons. 
This resistence is decreased in anemia. 
/\ 
'3. that there is a relationship between the mucosal bloc and storage 
iron. Hahn showed that when a normal dog is bled severely to produce an 
acute anemia, the rate of iron absorption remains normal for about a week 
and only after that does the rate of absorption increase. Granick deduced 
from this that increased absorption does not occur until the tissues, 
including the intestinal mucosa, are depleted of ferritin. 
4. that the level of ferritin in the mucosa of the duodenum increases 
for several hours after a dose of iron has been fed and then decreases 
slowly for several days. Therefore the presence of ferritin is connected 
with the presence of the mucosal bloc. "Only when ferritin in ~he 
mucosal cells was depleted would more ferrous ion be absorbed.f 
5. that the level of serum iron does not alter iron absorption. 
This conclusion is based on an experiment by Dubach (43) in which she 
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fed iron to an anemic dog immediatelv after saturatinJ the dog's serum 
with iron, but found no decrease in absorption. 
Putting these facts together, Granick evolved the following theory: 
j(··,,c; 
1. Ferrous'¥pass.e( into the mucosal cell from the intestinal lumen 
but cannot pass back into the lumen again. 
2. Once in the cell it is rapidly oxidized and bound to apoferritin 
or ferritin. Apoferritin is constantly being generated and destroyed 
in the cell, but it is stabilized by binding with iron and theeefore 
ferritin accumulates. 
3. Ferritin accumulation in some way diminishes the uptake of iron 
by the mucosal cell. 
4. There is a gradient of reduction in the cell, that portion bordering 
on the gut lumen being less reducing for ferric ion and that portion 
close to the bloo~ stream having a high reducing ability for ferric 
ion. Fertic ion is therefore reduced at the blood stream end of the 
cell and passes as ferrous ion into the blood stream where it is bound to 
siderophilin. In anemias the oxygen supply to the mucosal cells is reduced 
thus increasing the reduction gradient in the cell. This then results 
in a more rapid transport of iron from the gut into the body. Part of 
the ferrous ion might pasr straight through the ceU. without first 
being bound to ~erritin. 
5. As iron leaves the cell the ferritin is catabolized and the full 
ability to absorb iron is restored again. 
In support of the mucosal bloc theory, though not cited by Granick, 
is the finding by Hahn (44) that when a large oral dose of iron given to 
an anemic dog was followed by a tracer dose of radioiron, the second dose 
is less well utilized than it would have been h~d it been given alone. 
Also in suppoet of Granick's theory is the recent observation that 
rats kept in an hypoxic environment absorbed more iron than the ratas 
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under normal oxygen tension (95,96). 
SerioBs objections can be raised to the premises upon which this 
theory is fottnded and also to the theory itself. The misinterpretation 
of McCance and Widdowson's experiments which has resulted in the 
assumption that there is no fecal excretion of iron has already been 
discussed. Granick perpetuat·"'S this misinterpretation to support his 
conclusion that there is one way transfer of iron across tha intestinal 
mucosa. There is no good reason to assume that two way trans~er does not 
occur, at least to some extent. Granick must be roughly correct however. 
The statement, in fact, is almost a truism. If transfer i'rom gut to blood 
stream did not predominate over transfer in the opposite direction there 
would be no iron absorption• 
The observation that iron absorption is increased in iron deficiency 
anemia is well documented (33). That absorption is also increased in other 
anemias is less well documented. 
The study so frequently cited in proof of the thesis that absorption 
is increase4 in various types of anemia is that of Dubach et al (33). 
In this study a number of differBBt anemias were tested but significantly 
increased absorption was demonstrated only in two cases of anemia 
secondary to Hodgkin's disease. Studies on the anemia of infection ip 
animals have yielded contradictary results in respect to iron absorption. 
Schafer (47) found that infected mice absorbed moDe iron than normals. 
Hwever, Gubler (48) found the opposite to be true. The presence of 
varying degrees of hemosiderosis associated with a number anemias (pernicious 
anemia, hemolytic anemias, anemias secondary to malignancy) certainly 
suggests increased absorption. Gross et al (49) noted a substantial 
increase in the iron conteat of liver and spleen in a large n~~ber of cases 
of secondary anemia, mostly cases of malignant disease. However, they 
also noted that the size of iron stores was more closely correlated with 
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the degree of malignancy than with the degree of anemia. In a few cases 
of metastatic malignancy without anemia there were enormous amountSof 
iron in the liver and spleen. It has not yet been established that iron 
absotption is increased in all anemias. Furthermore, in those anemias 
which are associated with increased iron absorption, it ia not always the 
anemia which is responsible for the increase. 
This is an important point, because if it is the hemoglobin level per se 
which regulates iron absorption than the absorption should be increased in any 
anemia and the extent of the increase should be directly proportional to 
the severity of the anemia. This has not been proven to be the case. 
Granick's hypothesis that anemia increases absorption by reducing the 
oxygen supply to the mucosal cells is interesting but as yet unproven. 
The fact that rats in an hypoxic environment absorb more iron than rats 
under normal oxygen tension is certainly suggestive but the difference 
might be due to a differeace in gut motility rather than to a difference 
in oxygen supply to the mucosal cells. 
The relationship between anemia and absorption is, according to 
Granick, altered by the state of tissue iron stores. The assumption ,r 
both Hahn and Granick that increased iron absorption normally occurs 
only after depletion of storage iron is founded on experimeats of Hahn 
already alluded to. In these experiments absorption was determined by 
measuring red cell utilization of radioiron. The fallacy of equating 
absorption with red cell utilization has been demonstrated by Dubach (33). 
A detailed discussion on this point can be found in Joseph's 1958 re,new (29). 
There is, in fact, a good deal of evidence that the amount of storage iron, 
unless extrefmly eEcessive ( see pagej1) has very little to do with iron 
absonption. Haskins (50) found that iron absorptio~emained high in 
anemia while the hemoglobin level was rising but that, after a normal level 
of hemoglobin was attained, absorption decreases even though iron stores 
were still depleted. Dubach (33) found that a high rate of ahsorption 
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was maintained as long as hemoglobin levels were still low, even though 
enough intravenous iron had already been given to fill tissue iron stores. 
There have certainly been numerous examples of re~osiderosis in which iron 
absorption was normal or increased. Actually, Granick did not need to post• 
ulate depletion of general tiss~e stores as a prerequisite to increased 
iron absorption, The mucosal bloc theory requires only that the duodenal 
mucosa be depleted of iron for increased absorption to occur. The 
possibility exists that the duodenal mucosa is depleted of iron in 
prefereace to other tissue stores, but this has not yet been demonstrated. 
There is little to indicate that a mucosal bloc, in an active sense, 
exists at all. The rise and fall in ferritin content of the mucosal cells 
has been well demonstrated but no one has as yet presented convin~ng 
ev.idence that the rate of absorption is inversily proportional to the 
ferritin content of mucosal cells or that a saturaiton level of mucosal 
cells can be reached. The experimental observations of Hahn (44) that 
a second dose of iron is not as well absorbed as a first large dose can not 
be relied upon because, again, absorption has been equated with red cell 
* utilization • The crux of the matter is that, when high enough doses of 
iron are given, positive iron balance inevitably results. This was shown 
by Widdowson and MCCance (4) who succeeded in producing in normal young 
adults positive balances as high as .5.8 grams. in a prcriod of only six 
weeks. Re~man (1.5) demonstrated in dogs that lethal doses of iron can 
be absorbed from the gut through an intact mucosa in the absence of any 
necrosis of mucosal epithelium. There is certainly ample evidence 
*In particular, enlargement of the labile iron pool by the initial large 
dose of iron may have depressed the red cell utilization of the later 
administered isotope (utilization attaine:Ji in a given period of time). 
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that a mucosal bloc does not exist against large doses of oral iron. Is 
there an effective mucosal bloc in the presence of more moderate amo11nts 
of iron? To demonstrate such a bloc one would have to show that the 
efficiency of absorption decreases as the iron intake increases. Such 
a relationship has n.vw.e been demonstrated. Josephs (29),in fact, has 
indicated from a careful evaluation of the results of many iron balance 
studies that the effi,ciency of absorption does not change with the amount 
of iron ingested. A person who absorbes 10% of a 10 mg. dose of iron will 
in all prebability also absmrb 10% of a 20mg. or even a 40 mg. dose of 
iron • 
There is an important sense in which a mucosal bloc to iron absorption 
does exist. The mucosa normally limits the rate at whivh iron is released 
into the blood stream so that the iron binding capacity of serum is not 
exceeded. The rate at which iron is released from mucosal cells is the 
consequence of iron hinging by ferritin. Only in the presence of another 
iron binding protein (i.e. siderophilin ) does iron tend to be released 
from ferritin. The ability of the intestinal mucosa to limit the rate of 
iron release into the general circulation can be overcome with large doses 
of iron. Reisman (15) demonstrated this fact in dogs. Dosrs of 250 mg. 
Fepper lfg. of body weight resiUted in serum iron concentrations as high 
as 7 mg per 100 ml. Apparently, in the presence of such large doses of 
iron, ferritin synthesis can not keep pace with iron ingress and some 
iron passes through the mucosa in the ferrous form. 
There is also another sense in which a mucosal bloc may ex::i$t. The 
experimental observations of Taylor, Stiven and Reid (52)(see page~~) 
suggest, though they do not prove, that an intact mucosa is neeessarv to 
limit iron absorption. When the~is atrophy and necrosis of the epithelium 
of the intestinal vill~e, iron absorption appears to be greatl~ increased • 
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A number ef experimental and clinical observations, therefore, indicate 
that Granick's theory of the mncosal bloc is not a satisfactory explanation 
for the mechanism of iron absorption. A base-line inefficiency of absorptien 
is ordinarely maintained, perhaps through the presense of an intact cellular 
membrane. Experimental evidence does not support the belief that absorption 
can be further lim:l ted by metabolic alterations in the mucosal cells. The 
amount of iron absorbed is directly proportional to the amount of iron 
administered. The regulation of iron absorption appears to operate through 
an increase rather than a decrease in the efficiency of absorption. The 
mechanism by which this comes about is not understood. Certain fundamental 
relationships remain to be established. Is increased absorption primarely 
correlated with a decreased hemoglobin level, with an increased tissue 
avidity for iron or with some other less obvious factor? Intuitively it 
would seem as if tissue avidity for iron( the tendency for tissues actively 
to remove iron from plasma"(29)) is the final determinant of iron absorption. 
However, experimental evidence thus far has indicated that tissue avidity 1 to 
the extent that it is manifested in the serum iron concentration and in the 
turnover rate of serum iron, does not influence iron absorption(43 148). 
2. Factors which tend to increase iron absorption. 
A. Intraluminal factors. 
(1) Free iron salts alone are better absorbed than iron contained 
in food or iron given along with food(29). 
(~) Ascorbic acid, HC~ and other reducing substances. (29). 
As iron is probably absorbed in the ferrous form, reducing 
substances should favor absorption. HCl is such a reducing substance and it 
was believed for many years that gastric acidity was essential for adequate 
iron absorption. However 1 more recent evidence indicates that the presense of 
HCl is unimportant to iron absorption. Ascorbic acid is another reducing agent 
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for iron and in large doses ( around 1 gram) ascorbic acid will greatly 
enhance iron absorption. It has been suggested, however, that ascsrbic 
acid increases iron absoDption not by virtue of its reducing capacity but 
because~ it forms a soluble and absorbable chelate with iron (6). 
B. Internal factors: 
(1) Decreased intestinal motility 
A decrease in intestinal motility can increase iron absorption 
as well as the absorption of any other food stuff. This important iactor 
is seldom taken into consideration in iron absorption studies. 
(2) Growth and pregnancy 
Children absorb iron more efficienlhly than adults. During n 
pregnancy the efficiency of iron absorption is increased (29). 
(3) Anemia 
The effect of anemia on iron absorption has already been discussed. 
(4) Pancreatic insufficiency and vitamin A lefieie~y 
Taylor, Stiven and Reid (52) ligated the pancreatic ducts of cats 
and noted that over a period of time hemosiderosis developed. Associated 
with the development of hemosiderosis was atrophy and necrosis of apical 
epithelial cells in the villi mn the upper part of the small intestine. 
Cats fed vitamin A deficient diets also developed hemosiderosis and 
\II' . c 
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identical intestinal mucosal lesions. On the other hand, when cats with 
ligated pancreatic ducts were fed diets fortified with extra vitamins, both 
hemosiderosis and the intestinal lesions were prevented. Vitamin A 
deficiency, therfore,may result in hemosiderosis,as may also pancreatic 
insufficiency, by virtue of decreasing the absorppion of vitamin A. These 
interesting experiments also suggest, though thsy do not prove, trat atrophy 
\ 
and necrosis of the epithelial cells of the intestinal villi may result 
in increased iron absorption. Hemosiderosis is an almost constant autopsy 
~ 
t' v ! finding in children who die with fibrocystic disease of the pancreas (54) , 
.. $til' 
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·. · , , suggesting that the relationship between panceeatic insuffieiency and 
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" \ f !)C hemosiderosis holds true for humans as well as cats. The hemosiderosis 
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1, of fibrocystic disease cannot be attributed to anemia as anemia is uncommon 
in this disease(55) • 
. (5) Pyrodoxine deficiency 
Gu~er et al (56) noted that pyrodoxine deficient rats accumulated 
more iron than control rats. The hemoglobin levels of the pyr~doxine 
deficient rats were normal. 
(6) Chronic malnutrition. 
The high incidence of hemosiderosis ( with or w'thout cirrhosis) 
in malnourished individuals is well documented (57,J8). 
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(7) Copper 
Many years ago F.B. Mallol"Y' argued that chronic copper poisoning can 
cause he1110Chro•tosis(59,60). He was actually never able to demonstrate this. 
A thoDough critique of this point of view can be found in Sheldon's monograph 
on hemochromatosis(l). More recently, Chase(66) studied the relation of copper 
to iron absorption. He found that rats with abnormally low tissue levels of 
copper absorbed less iron than nol"llllll. Amounts of dietary copper up to levels 
or o.25-o.5o mg. per rat per day favored iron absorption, but with higher 
amounts there appeared to be reduced iron absorption. The infiuence of copper 
on iron absorption was related to tissue levels of copper rather than to the 
simultaneous administration of copper and iron. 
III IRON ABSORPTION IN IDIOPATHIC HEMOCHROMATOSIS 
It is obvious that patients with idiopathic hemochromatosis must 
have absorbed, at some period of their lives, abnormally large quantities 
or iron. In those cases where a caretul dietary histol"Y' was taken, there was 
no evidence or unusually large iron intakes ( 64) • These patients, therefore I 
lllU.st have absorbed what iron there was in their diets with abnormal efficiency. 
In any given case, however, the possibility of iron overload as the result ef 
excessive intake DIUst first be ruled out. There are now several cases on record 
of people developing hemochromatosis after taking oral iron medication .._r,y d~ 
for years. These cases will be discussed presently(see page~!). In idiopathic 
hemochromatosis, however, the fault lies in a disturbance of absorption. 
Interestingly enough, although increased absorption has been demonstrated 
by balance studies in anumber of cases(6,33,34,61), in at least an equal munber 
of cases no such abnormality of absorption could be demonstrated(6,34,62). 
Among nine patients with advanced hemochromatosis studied by Chodos(62), eight 
absorbed no more of a given dose of iron than did normal controls • Ther are 
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two possible explanations ~this. Either there is considerable variation 
in how much a patient with hemochromatosis will absorb from day to day, 
so that a normal amount is absorbed on one day and an abnormal amount is 
absorbed on another day, or, in the advanced stage of the disease, the 
disturbance of absorption, after having ~~ated for a number of years, 
may be overcome. Possibly when iron stores become very excessive, 
absorption is depressed. The former possibility finds supooat from a 
study by Bothwell (34) in which radioiron balance studies were done twice 
on each of three patients with idiopathic hemochromatosis. In two of the 
three cases there was a wide variation in the efficiency of absorption from 
one time to the next. One 53 year old patient absorbed 24% of the first 
dose and 77% of the second dose. Another 54 year old patient absorbed 8% 
of one dose and 35% of another dose. 
The second possibility, that iron absorption becomes normal after 
iron stores have accumalated for a number of years, is rendered likely by 
the studies of Chodos (62), Two of the nine patients studied by Chodos 
underwent extensive uenesection therapj. In one of these patients iron 
absorption studies were done both before and after the full program of 
venesections. Prior to therapy this patient absorbed only 6~ of a 40 mg. 
dose of FeDl2 on two different occasions (59). Following the removal of 
25 liters of blood over an 18 month period, ~s patient absorbed and 
utilized in his red cells !0% of a dose of ~ec12 • At the time of the test 
his hemoglobin was not stated to have been normal, but his serum iron was 
down to 60 micrograms per 100 ml., ,uggesting the onset of an iron deficiency 
anemia. However, on a l'ter occasion, after the seru~ iron had risen to 
120 micrograms per 100 ml., he still absorbed and utilized in his red cells 
54.5% of a dose of FeC12• A second patient was studied only after 
extensive venesection. He absorbed and utilized 8R.5% of a trace~ dose of 
radioiron. In a case studies by 'eterson and Ettinger (61) there was an 
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abnormally high absorption of iron immediatel~r follow:tng co:n.pletion of 
venesection therapj•· At that time a definite iron deficiency anemia was 
present. But 3 and i months later, after correction of the anemia, 
absorption was as high as in the first instance. Unfortunately, iron 
absorption was not studied in this patient before commencement of venesections. 
The hypothesis that very extensive iron stmres may depress iron absorption 
and that extensive venesection, therfore, restores the previously existing 
high rEte of absorption is certainly an attractive one, but this auther 
has not been abl~o find any other case in the literature, besides the one 
presented by Chodos, in which absorption studies were done both before 
and after venesection. This hypothesis, therefore, awaits fUrther 
confirmation. The consistency with which Chodos found normal iron absorption 
in advanced, untreated cases of hemochromatosis suggests that the variations 
Bothwell found in a smaller nVmber of cases are the exception rather than 
the rule. That iron absorption becomes normal in advanced hemochromatosis 
and that this is in some way related to the extensiveness of iron stores 
seems the more likely possibility at this time. 
What is the cause for the increased iron absorption that occurs 
in idiopathic hemochromatosis? 
Sheldon believed that there is an inborn error in metabolism which 
is responible both for the increased iron absorption and for the development 
of cirrhosis. Granic~ (7) believed that an inborn error in metabolism 
resulted in increased absorption and that the iron deposition than caused 
cirrhosis. The postulated metabolic de'fect is not a failure of ferritin 
formation. Granick demonstrated normal amounts of ferritin in the intestinal 
mucosa of a person who diel of typical idiopathic hemochromatosis (63). 
He therefore hypothesized: 
"It seems more likely that the metabolic error in hemochromatosis 
might be due to a slightly greater reducing tendency of the cell for iron. 
This would permit somewhat more iron to pass to the blood stream than in 
the normal. The greater reducing tendency or the lower 'redox' level 
might arise either by an increased effec~veness of the reducing enzymes 
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or might be brought about by a decrease in the effectiveness of the 
•xidizing enzymes. "(7) 
No one has as yet tested this hypothesis either ih normals or in patients 
with idiopathic hemochromatosis. The concept as it stands now is perhaps too 
vague for experimental demonstration to be possible. FUrthermore, it is 
derived from the theory of the mucosal bloc and the same objections which 
were raised against that theory can be raised against this hypothesis. 
The observations of T~or(52) on the etiology of hemosiderosis in cats 
raise. some interesting possibilities with respect to idiopathic hemo-
chromatosis. Pancreatic fibrosis and atrophy of pancreatic epithelium are 
almost constant findings in idiopathic hemochromatosis. One wonders 
whether these morphological alterations might not be associated with chronic 
functional insufficiency of the pancreas and w~ether this might not be 
an important cause of the iron overload. Alth~sen (64) studies pancreatic 
~ 
~ 
function in a number of patients with idiopathic hemochromatosis. He noted 
decreased trypsin activity in 5 out of 13 patients and decreased total 
bicarbonate secretion following secretin stimul&aion in only 1 of 7 patients 
studied. Stool examinations showed no significant evidence of malabsorption 
or underdigestion. He also noted that the outcome of the tests bore no 
relation to loss of weight or caloric intake in his series of patients. 
Althousen suggests that there is a compensatory prolongation of digestion 
and absorption in the small intestine in the cases where a degree of 
pancreatic insufficiency is present. 
Althousen's findings, therfore, do not point to pancreatic in-
sufficiency as a cause for increased iron absorption in hemochromatosis. 
There was some degree of pancreatic functional abnormality in a minority 
of patients, but nothing to suggest a malabsorption syndrome. McAllen (65) 
studied pancratic function in 6 patients with proven idiopathic hemo-
chromatosis. His findings confirm those of Althousen. 
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The possibility exists that increased iron absorption in hemo-
chromatosis may be the result of atrophic changes in the epithelium of the 
intestinal mucosa from causes other than vitamin A deficiency. This author 
could find no information on this point in the literature. 
The absorption defect in hemochromatosis may not be primary in the 
intestinal mucosa. One could postulate an increased affinity of paren-
chymatous tissues, especially }R the cirrhotic liver, for iron. One could 
go further and postulate an insatiable requirement of the tissues fir iron: 
no matter how much iron entered the cells, the cells reouired sttll more 
( see Gillman's theory, page~t). But this is too much in the realm of 
fancy. As was already mentioned, experimental evideDce does not supoort 
a cause and effect relationship between increased tissue demands ~r iron 
and increased iron absorption. One cannot help but feel, however, that such 
a relationship does exist. Further experiments may elucidate it. Of more 
immediate importance is the fact that in idiopathic hemochromatosis tissue 
avidity for iron may not be increased at all. In the next section evidence 
will be presented indicatinl that the cirrhotic liver does have an increased 
affinity for iron. Evidences to the contrary, however, are the elevated 
serum iron level and the prolonged half-life of serum iron, both 
characteristic of idiopathic hemochromatosis. These evidences to decreased 
tissue avidity for iron may be late manifestations of the disease, the result 
of supersaturation of the tissues with iron. However, McAleen (65) noted 
in several hemochromatotic patients whose iron stores were completely 
depleted by repeated venesection that the serum iron levels, after being 
low for a short time returned to higher than normal levels. This is 
surprising information. Fir if tissue affinity for iron were greatly 
increased in hemochromatosis, one would expect l~serum iron levels for 
many years folloqng depletion of iron stores. This one report requires 
corroboration. Taken at face value it strongly suggests that in idiopathic 
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hemochromatosis iron absorption runs ahead of tissue utilization. Iron 
overload, therefore, may be forced onto the tissues due to a primary defect 
in absorption and not be secondary to increased tissue demanas for iron. 
rf. THE DISTRIBUTION OF IRON OVERLOAD (28,32,40,49,51,67-77) 
Information about the distribution of iron overload can be derived 
Hoth from human autopsy material and fro~ studies en c~erL~en~ally induced 
hemosiderosis in animals. There is a good deal of confusion and also some 
conflicting observations in the literature on this subject. Species 
variations, variations from one individual L~ the species to another, 
variations in the form of iDon administered, the route of administration, the 
dosage, the duration of time over ~mich the iron is administcrPd and the time 
which has ~aesed since the cessation of iron administration and the cessation 
of life- all these factors influence the distribution of iron in the tissues 
and make it impossible to outline very precisely the pattern or patterns of 
distribution. However, certain generalizations can be made. It is also possible 
to suggest a few of the factors which determine or alter this distribuumon. 
1. Iron which is administered in the colloidal form is initially deposited 
exclusively within the reticuloendothelial system. 
This applies to iron administered as red cells, free hemoglobin, 
colloidal or saccharated iron oxide, iron ascorbate-gelatin and iron-dextran 
(Imferon) (28,32,68-73,75). When an animal is killed shortly after receiving 
a large intra venous dose of colloidal iron, the princi;ik sites of deposition 
. A.. 
will be the spleen and the lupffer cells in the liver. (If the iron particles 
have caused capillary damage, deposits in the glomeruli and/or the renal 
tubules and in the lung parenchyma will also be seen.) 
2. Iron which enters the bogy in an ionic or readi~ diffusible form 
is initially deposited both in parenchymal and reticuloendothelial sites. 
This apllies to ionic or readily diffusible iron given parenterally 
and to iron absorbed from the intestine. When an iron salt is given 
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intravenously in excess of the serum iron binding capacity, the more 
noticeable comcentrations of iron will be in the hepatic parenchyma, the 
acinar cells of the pancreas, the spleen and the renal tubules (28,74). 
3. Following initial deposition a secondary redistribution of the iron 
occurs along a pattern which is characteristic of the particular animal 
or of the particular disease state and which is also partly determined 
by the total amount of iron administered. 
A .. The long term redistribution of colloidal iron 
~1) lver a long period of time, the amount of iron in the liver 
increases and the amount of iron in the rest of the body decreases. There 
is a shift of iron to the liver which is the primary storage organ for iron. 
However, when extremely large doses of iron are given, the storage capacity 
of the liver may be exceeded and the iron deposition is increased in other 
organs (51, 68-70). 
(2) The iron initially present in the Kupffer cells of the liver 
is partly redistributed to the parenchymal cells. First there is a diffuse , 
fine granulation at the periphery of the lobule, then the entire lobule 
becomes involved and fine granules clump tovether to form coarse granules. 
If no more iron is administered, parenchymal iron deposition will reach a 
maximum after a number of months and then gradually decrease. During this 
entire process, Kupffer cells laden with iron have clumped together to form 
giant cells which migrate into the portal tracts. Eventually most of the 
iron may leave the liver through the lymphatics and be deposited in the 
abdominal and posterior mediastinal lymph nodes (68, 70). 
(3) If colloidal iron is repeatedly administered up to the time 
of autopsy, the predominant iron distribution will be reticulo-endothelial, 
because redisDribution of iron cannot keep pace with primary deposition.(32,51, 
71,72) Extrahepatic iron stores will also be striking. These stores will 
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not yet have been distributed to the liver. Also, if enough iron has been 
administered, the storage capacity of the liver may have been exce8ded. In 
cases of severe transfusion hemosiderosis studie~ by Cappell (51) there was 
extensive iron deposition in the liver, spleen, bone marrow, pancreas, 
* stomach, choroid plexus, thyroid and adrenals. 
B. The long term redistribution of iron absorbed from the intestine 
(1) During the initial plase of e&cessive iron absorption, the liver 
and the reticulo-endothelial tissues show an increased iron content. As 
excessive absorption continues, the absorbed iron is taken up a~ost 
quantitatively by the liver. Finch ( 28) demonstrated this point in mice: 
Ji\i. \-e. 
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(2) Unfortunately, this experiment was not continued beyond 24 days. 
Presumably, after a long period of excessive iron absorption, the storage 
capacity of the liver for new iron decreases and iron depositions occur in 
* Brown et al (32) noted an almost exclusively reticulo-endothelial 
distribution of iron in dogs which had been injected or transfused with 
colloidal iron in amounts comparable to what is seen in hemochromatosis. 
These dogs were studied for periods up to 7 years. The iron was administered 
for periods up to 10 months in duration. Outside of the reticulo-endothelial 
system there only small amounts of iron in the liver parenchyma, the renal 
tubules and the breast. This suggests that the form of iton administered 
not only determines what will be the initial distribution of iron but also 
may cause a specific alteration in the individual's basic redistribution 
pattern. In these dogs there seems to have been an adaptation of the 
reticulo-endothelial system to iron overload: its capa~ity for iron 
storage and its affinity for iron increased. 
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other organs. Dogs kept on a low phosphorus (corn grit and 2% ~erric 
citrate) diet for periods of time ranging from 2-6 months showed an 
overall parenchymal distribution of iron which Finch considered to be 
similar to that seen in idiopathic hemochromatosis (28). Rather(74), on the 
other hand, found that, when he fed rats on a low protein and 6% ~erric 
citrate diet for periods ranging between 109 and 518 days, there was a 
predominantly reticulo-endothelial distribution of iron with relatively 
little involvement of parenchymatous tissues. This difference in distribution 
may be the result of a species difference in the handling of iron. The 
reticulo-endothelial system of rats show an unusually hit.h degree of activity •• 
C. Internal factors which may alter the distribution of iron. 
(1) Activa~on of the reticulo-endothelial system. 
In anumber of conditions of stress, dogs developf a hypoferremia 
which can be abolisbed either by bilateral adrenalectomy or by blocking 
the reticulo-endothelial system with thorium dioxide (76). Apparently, ~ 
under conditions of increased adrenocortical activity, the affinity of the 
reticulo-endothelial system for iron is increased. This phenomenan is not 
only confined to dogs. It has been shown that afterr~ewn a minor surgical 
operation a significant hypoferremia occurs in humans (77). The stressful 
conditions which, at least in amimals, result in increased affinity of the 
reticulo-endothelial system for iron are manifold: infection, sterile 
turpentine abscesses, anaphylactic shock, fractures, injections of histamine, 
epinephrine, ACTH or adrenocortical hormones (76). There also seems to 
br a correlation between the degree of lymphopenia and eosinopenia produced 
and the degree of hypoferremia which developes (76). 
Most of these observations were made by Cartwright, Gubler, 
Wintrobe and others in the course of their studies on the anemia of 
infection. They provide experimental evidence only for a shift of small 
amounts of iron to the reticulo-endothelial system. It is a possibility, 
though it does not necessarily follow, that the distribution of large 
amounts of iron might also be altered in chronic infections or other forms 
(!J/1.1 
of chronic stress. Direct experimental evidence is lackitng M this point. 
However, studies on experimental hemosiderosis underline the relative ease 
with which iron stores may shift from one tissue compartment to another. 
There seems to be a precarmous and often unpredictable balance between 
parenchymal and reticulo-endothelial iron stores. The possibility that 
certain forms of stress may alter this balance deserves investigation. 
Gillman, on the basis of his studies of Bantu siderosis in Africa, has 
indicated that such an alteration occurs in the liver in the presence of 
chronic or acute infection (78). 
(2) Inflammation, active fibrosis and liver cirrhosis 
A number of investigators have noted the tendency for hemosiderin 
to accumulate at sites of inflammation and developing .fibrosis. It has 
also been noted that the cirrhotic liver accumulates iron more readily than 
the normal liver. Polson (68) injected large amounts of colloidal iron 
into a group of rabbits, one of which was noted to have cirrhosis at· autopsy 
(cirrhosis is a frequent, almost normal occurrence in rabbits). In the 
normal rabbits iron did not appear in the hepatic parenchyma earlierthan 
S days following accumulation of iron in the Kupffer cells. In the cirrhotic 
rabbit, this time interval was shortened to two days. Rous and Oliver r73) 
were among the earliest investigators to note the affinity of inflammatory 
and cirrhotic tissue for iron. Their classic observations req1Jire no 
elaboration: 
" The rabbit material has furnished striking proof that when a 
tendency to siderosis exists, an intercurrent cirrhosis will greatly increase 
the deposition of pigment. In one transfused animal with a very moderate 
general siderosis of the liver an adhesion had occurred connecting the 
anterior edge of a lobe with the abdominal wall and thus inducing a well 
marked local cirrhosis. Here the liver cells were so heavily pigmented as in 
many instances to be scarcely recognizable and in others to have broken 
down. The contrast to the parenchyma elsewhere in the organ was extreme. 
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In a second animal, as well, a local cirrhosis of unknown origin was 
accompanied by great local pigmentation. It is perhaps not a matter of 
accident that the rabbit with the most pigmented liver has not been transfu~ed 
longest but was the subjedt of an intercurrent cirrhosis. In the course of 1 
167 days it had received 139 transfusions, 52 of 10 cc. each and the last 
87 of 15 cc. each. A companion animal of the same weight and sex, 
receiving in 194 days 156 transfusions, the last 99 of 15 cc. each had no 
cirrhosis of the liver and exhibited by contrast, little pigmentation." 
And later in the same article: 
"Signs of an old perirenal inflammation existed in one of the 
transfUsed rabbits, and in the scar tissue here numerous connective tissue 
cells were noted containing hemosiderin. The observation led us to inject 
agar into the other animals of the series some days before killing them 
with a view to determining whether iron would be laid down in the reaettve 
tissue. Such was the case. The cells in the interior of the agar mass 
were unpigmented, which was to have been exp ected, since they were in the 
process of rapid proliferation, but in the older reactive tissue hemosiderin 
was fairly abundant as small granules in the fibroblasts. Its constant 
presence and general distribution rules out the possibility that it was 
derived from local hemorrhage." (73) 
fj) Nissirnhas noted the almost exact parallelism between the 
distribution of iron and ascorbic acid in the tissues (75). 
HEMOCHROMATOSIS 
If hemochromatosis is defined quite simply as the concurrence of 
cirrhosis and extensive hemosiderosis, then there are a number of disease-
states which may be classified as hemochromatosis. First of ali~t~ the 
classical syndrome of hemochromatosis. Secondly, there is cirrhosis with a 
superimposed hemosiderosis. Whether this is a real entity, distinguishable 
from idiopathic hemochromatosis, is a matter of dispute. Another entity 
which some would distinguish from the idiopathic form of the disease is 
hemochromatosis occurring in conjunction with chronic refractory or 
hemolytic~ anemias. There is, next, the occurrence of cirrhosis in patients 
receiving multiple transfusions - an entity which some have chosen to 
call "transfusion hemochromatosis". There is the hemochromatosis which 
is so prevalent among the Bantus of Southern Africa, Fi.Bally, there is 
the rare but interesting occurrence of hemochromatosis in people who 
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have taken oral iron medication regularly for years. Each of these 
"entities" differs in some respects from the others. A study of their 
differences and similarities may contribute to an understanding of the 
pathophysiology of iron overload. 
I. IDIOPATHIC HEMOCHROMATOSIS ( BRONZE DIABETES) 
A. ¢linical picture (64) 
* This is predominantly a disease of males. The first symptoms appear 
in the middle decades of life. The initial symptom is usually either 
wealrness or diabetes. Less commonly, abdominal painpr symptoms from portal 
hypertension may be initially present. 'lhe diagnosis is not uncommonly 
made quite incidentally while the patient is in the hoppital for another 
reason. 
Blue-gray or brown pigmentation of the exposed areas of skin and 
atrophic changes in the skin are almost invariably present for a number 
of years before the onset of symptoms. Patients usually insist thvt. 
'\ 
their skin was pigmented all their lives. 
The primary symptoms are e%cessive weaXness, weight loss} loss of 
libido, diabetes and frequently, abdominal pain and a nonspecific sort of 
indigestion. Ascites and hematemesis from esophageal varices are uncommon 
and usually indicate terminal disease. Clinical enlargement of the liver 
is almost universll. In most cases liver function tests are only slightly 
,, 
abnormal. Marked abncrmali ties in liver function tests are rare except in the 
terminal stage of the disease. 
* Some 10% of cases are found in women. These women usually have a 
hiltOrJ ot reduced menstrual flow. The comparative rarity of severe 
hel*i>std:er<bstsd:!iinE!liomens:tsu.undcbub1redly due to the loss of iron through 
menstruation. . J,, 
1 
I{ 
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The frequent alteration of secondary sex charac~ristics is one of the 
more striking aspects of the disease. These alterations are far more common 
in idiopahbic hemochromatosis than in other forms of paeta1 cirrhosis. 
9 of 13 men studied by Althousen (64) experienced an abrupt or premature 
loss of libido. 12 of 20 had atrophic teste~. 13 of 17 had a slight to 
\.-'~~1~':'~ 
marked reduction in body hair. The pubic haiilnad a feminine distribution, 
Pancreatic exocrine functina in hemochromatosis was discussed in a 
previous section. 
Patients with hemochromatosis rarely give a history of inadequate 
dietary intake of essential food stuffs. Excessive alcoholic intake is 
fairly common, having occurred in one half of the cases studied by Althousen.( 
A small minority of the patients may have a megaloblastic anemia (?q-81). 
The large majority have normal hematacrits and hemoglobin levels. MBAllen, 
however, has pointed out the frequent presence of a macrocytosis (65). 
B. Pathology 
(1) Deposition of iron (1) 
Hemosiderin is predominan&ly concentrated in parenchymatous tissues 
with lesser amounts found in reticule-endothelial tissues. The largest 
amounts of hemosiderin are usually found in the liver and pancreas. The 
endocrine glands are usually heavily pigmented (parathyroids, thyroid, zona 
glomerulosa of the adrenals, anterior lobe of the pituitary, the islets 
of Langerhans) • A number of exoct'ine glands are also affected. Hemosiderin 
is found in the acinar cells of the pancreas, in tr--e serous secreting cells 
of the salivary glands, in the dermal sweat glands, in the chief ~ellasof 
the stomach, Brunner's glands in the duodenum, in the lacrimal glands, 
synovial membranes and the choroid plexus. Hemosiderin is often present 
in cardiac ITDlscle .fibers and, to a lesser extent, in skeletal ITRlscle. In 
skin the hemosiderin is located inadi around sweat glands and around blood 
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vessels. A small amount of hemosiderin can be found in the intersti Mal 
tissue of the testes but not in the germinal epithelium. Hemosiderin is 
notably absent from the central nervous system with the exception of the 
choroid plexus. 
The abdominal lymph nodes draining the liver and pancreas and the 
posterior mediastinal lymph nodes show large accumulations of hemosiderin 
but tre remainder of the reticulo-endothelial system is only moderately 
affected. The spleen and bone marrow1 in particular, usually show only 
small amounts of hemosiderin. 
$Reldon has estimated that the total body iron in patients with 
idiopathic hemochromatosis almost always falls in the range of 25-50 gms. 
The liver contains, on the ave~age, 3-4% iron by dry weight, the pancreas 
contains about 2% iron by dry weight and the spleen, 0.6~. 
(2) HemofUscin (82) 
In the past a great deal of attention was paid to the very 
noticeable presence in hemochromatosis of a brown pigment which does not 
give the Prussian blue reaction for iron. This pigment was given the 
name hemofUscin by Von Recklinghausen. It occurs chiefly in the walls of blood 
vessels, connective tissue of various organs, smooth muscle of the 
gastro-intestinal and genito-urinary tracts and epithelium of the genital 
system. Its chemical composition has never been established. The 
currently prevailing view is that it belongs to the familY of lipogenic 
pigments (lipofUscins) and is similar if not identical to the "brown 
atrophy" pigment of old age and cachexia. 
(3) Fibrosis, cirrhosis and aiirophic changes. 
Cirrhosis of the liver and fibrosis and glandular atrophy of the 
pancreas are, of course, the most prominant pathological changes. In 
addition, atrophic changes occur in the seminiferous tubules of the testes 
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and variable degrees of fibrosis can often be found in the thyroid gland, 
the salivary glands, the heart, the spleen and in the heavily pigmented 
lymph nodes. The amount of fibrosis found in the spleen is no more than 
one would expect in moderate portal hypertension.(l) 
The skin is mostly atrophic and there is an increased melanin 
content in the basal layers of the epidermis. Both bronze and blue-gray 
pigmentation have been described in hemochromatosis. It was believed at 
one time that the bronze color was due to the hemosiderin in the skin and the 
blue-gray to melanin. This view is no longer accepted. The difference 
in skin color is probably related to the variable thickness of the 
epidermis. Where the sktn is atrophic and the epidermis quite thin, 
melanin in the bas.a cell layer appears blue-gray on the surface. Where 
the epidermis is thicker, the color tends to be more brown (69). 
(4) Pathology of the liver (1,64,82) 
The characteristic microscopic appearance is that of a 
portal-type cirrhosis which is quiescent (82), i.e., there is no appreciable 
degeneration or necrosis of liver cells. Portal fibrosis, pseudolobulation, 
bile duct proliferation and nodular ~generation of parenchyma have all been 
noted to be present. The nodules are usually larger, morei~egular in size 
and shape, and the fibrous bands thicker than in the typical case of 
Laennec's cirrhosis. 
The quiescent character of the cirrhosis shoul« be stressed. 
Cellular degeneration and active regeneration have often heen reported but 
these reports are almost always based on post mortem examinations. 
Althousen(64), whose information came entirely from biopsy specimens, noted 
the almost invariable absence of cellular degeneration, young fibrous 
tissue and even recent active regeneration. The picture he noted was that 
of a cirrhosis of long standing with nothing to indicate any progression. 
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The occasional finding of more active cirrhosis at autopsy m~ perhaps be 
attributed to a terminal flare-up of the cirrhotic process. 
The typically quiescent, inactive character of the cirrhosis as it is 
seen in biopsy specimans casts some light on the role of iron stor es in tt.e 
cirrhotic process. If iron deposition is inducing active cirrhosis at the 
time of biopsy, the effect is so slight as to be imperceptible. It is more 
likely that either the iron is secondary or incidental to the cirrhosis or 
that the iron produced a cirrhotogenic effect at one time in the course of 
the disease but that a specific tolerance to the presense of iron later developed. 
Hemosiderin is found in the liver cells, in the Kupffer cells and in 
the portal tracts. When parenchymal tfp~ hemosiderosis is not all-pervasive, 
the hemosiderin is deposited chiefly at the periphery of the +obules. In those 
cells with moderate amounts of hemosiderin, where the cellular architecture 
has not been completely obscured, the hemosiderin is seen around the nucleus 
or at the biliary end of the cell. Young cells contain less pigment than 
mature cells. 
The Kupffer cells contain variable amounts of hemosiderin. In the portal 
t~ac~s, hemosiderin is found within macrophages, extracellularly, in the 
endothelium of capillaries and in bile duct epithelium. 
Usually more hemosiderin is found in parenchymal than in extra-parenchymal 
sites, but there are many exceptions. Dubin(82) noted that in the typical 
qpiescent case the bulk of the hemosiderin is found in the parenchymal cells. 
Sheldon(l), on the other hand, noted that in many cases the hemosiderin in the 
reticuloendothelial cells and fibrous tissue outweighed that present in the 
parenchymal cells. Dubin's observations on the prevelance of parenchymal iron 
in quiescent cases is no doubt pre~judiced by the fact that he does not make 
a diagnosis of hemochromatosis in quiescent cases unless the iron is predomin-
antly parenchymal in distribution. Where the iron is predominantly reticulo-
endothelial , he chooses to make a diagnosis of cirrhosis with 
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hemosiderosis • Sheldon was not thus prejudiced. 
The very labile nature of the balance between reticulo-endothelial and 
parenchymal iron stores in the liver was pointed out in a previous section. 
Dubin himself notes that when liver cells undeP.go acute damage as in fatty 
metamorphosis, the iron is released from the damaged liver cells and picked 
up by reticulo-endothelial cells. It would seem, furthermore, that such a 
transfer of iron might occur not only as a result of acute damage to the 
liver cells but also consequent to an increased affinity of the reticulo-
endothelial cells for iron. 
One cannot assume with any certainty that a particular case is not 
hemochromatosis because there is a quiescent cirrhosis with predominantly 
reticulo-endothelial distribution of iron. The attempt to distingui8h by 
this criteria between hemochromatosis on the one hand and cirrhosis with 
hemosiderosis on the other hand is predicated on the assumption that if 
hemosiderosis becomes superimposed on cirrhosisj most of the iron will be 
deposited reticulo-efothelially. Animal experiments, however, have indicated 
the opposite to be the case (28,74). Absorbed iron often has a primarily 
parenchymal distribution even in otherwise normal animal livers. Polson (68) 
and also Hous and Oliver (73) observed that, in the presence of cirrhosis, the 
tendency to parenchymal iron depostion is greatly exaggerated. Whether 
cirrhosis with hemosiderosis really exists as a distinct entity from 
hemochromatosis is a moot point. However, it seems fair to conclude that 
a differential diagnosis cannot be made on the basis of histologi~al 
examination of the liver. 
(5) Pathology of the pancreas (1,9,82) 
Some degree of fibrosis is present in almost every case and 
usually the fibrosis is quite advanced. There is a marked reduction in 
the amount of acinar epithelium and there are often degenerative ehanges in 
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the remaining acini. Deposits of epithelium are usually abundant in the 
acinar epithelium and the connective tissue. Small amounts of hemosiderin 
are found in the islets. Sheldon points out that in many cases the degree 
of pigmentation and the degree of fibrosis are not well correlated. 
The islets, according to Sheldon, are somewhat reduced in number, 
seldom fibrosed, but o.f'ten surrounded by a thick wall of fibrous tissue. 
There is no correlation between the presense or absemse of diabetes and 
the degree of pigmentation of the islets(9). Bell(9), on reviewing eight 
cases of typical bronze diabetes, noted no hyaline islets in any of the 
eight cases but noted marked degranulation of the beta cells in every case. 
II TRANSFUSION HEMOSIDEROOIS AND HEMOCHROMATOSIS ASSOCIATED WITH CHRONIC 
ANEMIAS. 
A. Transfusion hemosiderosis 
There have been a number of reports in the literature of hemochromatosis 
occuring in patients receiving multiple transfusions(5,6,83). Such reports 
are cited as proof for the contention that iron overload leads to cirrhosis 
and the full blown syndrome of hem.ochromatosis. Many of these reports, 
however, cite only those cases which were associated with cirrhosis. 
Reviewing these selected cases alone does not give one a conception of the 
actual incidence of cirrhosis in all eases of transfusion hemosiderosis. 
In 1954 Kleckner et al(84) and in 1956 W,yatt(85) reported series 
of unselected cases of transfusion hemosiderosis. 
Kleckner studied a series of 16 patients who had received from 10 to 
291 transfusions over periods ranging from several months to six years. 
None of these patients had diabetes and only one had pigmentation of the 
skin. 
Liver cirrhosis was present in only one case and in this case it 
had been present before ~ transfusions were given. In no case, therefore, 
so 
was transfusion therep,y asscociated with the development of cirrhosis. 
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In four cases there was a moderate degree of fatty infiltration. Centri• 
lobular hepatic necrosis of a mild degree was present in seven cases and 
of a moderate degree in two cases. Varying degrees of hepatic hemosiderosis 
were seen with involvement of liver cells, Kupffer cells, connective tissue 
of the portal. tracts and bile duct epithelium in some or all cases. In four 
cases the iron was predominantly parenchymal in distribution. 
Hemosiderosis of the pancreas was present in only these cases. 
Minimal pancreatic fibrosis was present in eight cases. Hemosiderin deposits 
in the spleen were noticable in aJ.most every case~ Mild to moderate splenic 
fibrosis was present in one half of the cases. Pigmentation of lymph nodes 
was generalized as opposed to the predominant involvement of the nodes 
draining the liver and pancreas in idiopathic hemochromatosis. The bone 
marrow and the renal. tubules were pigmented in about mw haJ.f of the 
cases. Hemosiderosis of endocrine glands occured in only a few cases. 
Wyatt reviewed 27 cases of transfusion hemosiderosis. The amount of 
iron transfused in each case varied from 3.5 to 77 grams • Twelve of these 
cases were classified as instances of "dysgenerati ve anemia." Fi.:rteen 
were classified as examples of" malignant lymphomatous disease." Clinical 
skin pigmentation occured in only' 3 of the 27 cases and diabetes was found 
in none. 
"Progressive liver fibrosis" developed in 7 of 12 caaes of dysgenerative 
anemia and in 2 of 15 cases of maJ.ignant lymphomatous disease. The patients 
with dysgenerative anemias had received, on the whole, more transfusions 
' 
over a longer period of time than the patients with malignant lymphomatous 
disease. There was, therefore, some correlation between the number of 
transfusions given and the incidence of hepatic fibrosis. There were, 
however, some significant exceptions. Some of the cases of heavy iron 
storage showed little or no fibrosis while, on the other end of the scale, 
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pigmenatary cirrhosis occurred i~atients ~o had received relatively 
few transfusions. This was the case in two children with Cooley's 
anemia. 
Concentration of iron in the parenchymal cells was nnted rrruch earlier 
in the course lymphomatous disease, although smaller amounts of iron had 
been transfused. This is an interestin~ observation in light of what was 
discussed previously concernmng the anemia of infection. It was noted 
then that the degree of hypoferremia, and therefore the increase in 
affinity of the reticulo-endothelial system for iron, is correlated with 
the degree of l~phopenia and eosinopenia that develope&. One can 
speculate as tb whether the corDllary to this relationship also holds 
true. When the reticulo-endothelial system is engaged in the excessive 
prDliferation of cells does it lose its capacity to store iron? 
The pattern of fibrosis in the 9 instances where liver fibrosis was 
noted was not the characteristcic pattern seen in idiopathic hemochroma-
tosis. In some area)of these livers the hepatic fibrosis simulated that 
of post-necrotic type whereas in other areas a more typical portal 
fibrosis was the rule. In three of the cases there was necrosis and 
inflannnation associated with disorderly proliferatioh of fil!PUW s \-\ \)n.::~-1~ 
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tissue revealing anp active process~ differentiating these cases from 
the typically inactive cirrhosis seen in idiopathic hemochromatosis. 
The extrahepatic pattern of iron distribution in the ~sgenerative 
anemias was comparable to that seen in idiopathic hemochromatosis with the 
except.ion that there were higher concentrations of iron in the spleen and 
adrenals in the former than in the latter. In the malignant lymp! omatous 
group the spleen showed a gradual increment of iron with a later reduction, 
indicating a redistribution of iron in the body. 
Recently Cappell (51)reported 5 cases of transfusion hemosiderosis in 
none of which cirrhosis developed. LIBRARY 
BOSTON UNIVERSITY 
SCHOOL OF MEDICINE 
.~ , 
ANALlSIS OF CASES OF TRANSFUSIONAL SIDEROSIS 
Cue sex Amount transfused Duration Estimated iron (g.) 
no. and Blood dyscrasia Blood transfusions recovered from 
age (litres) Iron( g.) (years) liver sleen 
1 M. 71 Refractory megalocytic 2.5+ 12 • .5 8 •••• • ••• 
anemia with 
hypocellular marrow 
2 M. 64 Idiopathic aplasia 27 13..5 2..5 .5 0.4 
3 F. 72 Non-regenerative 94 47 3 2.5 o.5 
anemia 
4 
4 M. 44 Osteosclerosis; 415 210 12 .5.5..5 10 ~ aplasia 
.5 M. 67 Idiopathic aplasia 30.5 1.52 6.5 .57.75 28 
-from Cappell et al. (51). 
In only cases 4 ~ 5 was there pigmentation of the skin. 
Pronounted hemosiderosis of the organs was present in all the cases with 
the liver, spleen , marrow, pancreas, stomach, chormid plexus, thyroid and 
adrenals being most nota',ly affected. In no case was there evidence of 
fibrosis in any of the parenchymatous organs. The absence of cirrhosis is 
particularly significant in cases 4 and 5, where the livers contained 
amounts of iron more than equal to that found in idiopathic hemochromatosis. 
The livers were greatly enlarged in these latter cases. The aut~ors 
attribute the hepatic enlargement to swelling of hepatic cells with 
hemosider.hn, broadening of the portal tracts Qy accumulation of hemosiderin 
laden macrophages and some hyperplasia of liver cells. 
All the livers showed hemosiderin accumulation in both parenchymal 
~iA.t-
and reticulo-endothelial cells, ·~ these elements were not affected with 
proportionate severity in each case. The hepatic iron distribution in 
cases 1, 3, 5 was more markedly reticulo-endothelial than in cases 2 and 4. 
ih 
Pigmentaticn of the parenchyma reacheAVg""reatest intensity in case4. There 
was an attack of homologoud serum jaundice one year before death, which 
may or may not be related to the predominantly parenchvmal distribution 
of pigment in this case. 
The pancreas showed hemosiderin deposition in the acinar cells and 
islets but there was no atrophy or fibrosis except in case 3 which showed 
fatty infiltratmon and atrophy of acinar tissue. The spleen and bone 
marrow showed considerable iron deposition. In the lungs the alveolar 
phagocytes were heavily laden with iron, but, in contrast to idiopathic 
pulmonary hemochromatosis, there was no iron impregnation in the elastic 
-...kt. 
tissue and reticulum of the lung parenchYIJB. and blood vessels. ii c;idneys 
u.t 
contained very little iron. 'I Testes in case 4 (age 44) showed some atrophy 
of the seminiferous tubules and absence of spermatogenesis. In this case 
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skin pigmentation was also present. It is interesting that these- two 
characterictic features of idiopathic hemochromatosis occurred in t"he 
absence of liver cirrhosis. The possible etiologic role of iron in the 
developement of testicular atrophy will be discussed presently. The testes 
in this case showed a pattern of iron depeeition identical with that seen 
in idiopathic hemochromatosis - hemosiderin in the connective tissue and 
a slight amount in the cells o .. eydig but none in the cells of the 
seminiferous tubules. 
On the basis of theses cases and on the basis of his own review of 
the pertinent literature, Cappell concludes that iron administered through 
mu1 tiple transfusions is not cirrhotogenic. In reviewing 19 cases of 
transfusion hemosiderosis from the li te~re, in wllich bojrh the amount 
of iron administered and the amount of iron present in the liver post-
moDtem are recorded, Cappell noted a fUndamental difference between those 
cases where cirrhosis deve~oped and those cases where cirrhosis did not 
developJ. In 7 of the 9 cases with cirrhosis more irom was found in the 
liver than had been administered parenterally, while in only one of the ten 
cases without cirrhosis was the hepatic iron in excess of the administered 
iron. It is concluded from this dti.fference that in the cases where cirrhosi s 
developed there was a significant increase in the intestinal absorption of 
iron and that this abnormality may be closely related to the developement 
of cirrhosis. 
This i~ a tempting conclusion to draw but it is not entirely 
justified. Since the total amount of boby iron is not known in these 
cases it cannot be aaid with anJ assurance that more iron was ibsorbed 
from the intestine in the cirrhotic than in the non-cirrhotic cases. In 
view of the increased tendency to absorb iron in a number of the anemias, 
it is possible that considerable amounts of iron were absorbed from the 
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intestines in all of these cases. It may be that where cirrhosis 
developed, proportionately more of the body iron concentrated in the liver 
than where cirrhosis did not developf. The difference, therefore, might 
~ 
be one of distribution than absorption. 
The investigations of Kleckner (84), Wyatt (85) and Cappell (51) 
indicate that cirrhosis develop~s in only a small minority of the cases of 
transfusion hemosiderosis. ~rthermore, presence or absence of cirrhosis 
is not too well correlated with the number of transfusions given. In those 
cases where cirrhosis did developi, it was usually not the characteristic type 
of cirrhosis seen in idiopathic hemochromatosis. 
B • Hemochromatosis in chronic anemias 
The problem of deciding what part iron overload from transfusions 
plays in the production of cirrhosis is an exceptionally difficult one 
because chronic, unremittant anemias, even in the absence of transfuSions, 
are sometimes complicated by cirrhosis. Koszewski (79) noted that 9 out 
of 35 cases of hemochtomatosis occurring in Switzerland were associated 
with a megallcytic anemia. Sases of hrmochromatosis in association with 
megaloblastic anemia have also been reported by MUinaaad (86) and, more 
recently, by Granville and Dameshek (81). In the case reported by 
MUihhaad 3 grams of iron w2re given bJ' transfusion over a 9 year period, 
certainly not enough to account for the hemochromatosis. In Qranville 
and Dameshek's case the presence of pigment cirrhosis was proven by liver 
biopsy before any transfuSions were administered. Hemochromatosis has 
occurred in association with paro~smal nocturnal hemoglobinuria (86). 
Whipple and Bradford (67) reported post mortem findings on three 
young children who died rrl.th Cooley's anemia. In each case there was a 
~ 
hemosiderosis rrl. th-.. typical iron distribtution of idiopathic heme-
chromatosis. Cirrhosis was not noted, but as the oldest child died at the 
age of seven, it is possible that cirrhosis might have developed had the 
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had the children lived lmnger. 
The similarity b•tween the distribution of hemosidern in Coiley's 
Ci.IU. 
anemia and in idiopathic hemochromatosis is striking. ThereYtwo possible 
sources for the tissue iron deposits in Cooley's anemia. The iron may be 
directly derived tldls~f.rom hemolyzed bldd or from iron absorbed from the 
intestines or from both sources. The pattern of iron distribution 
suggests that hhe deposits are primarily derived from absorbed iron. One 
might picture the process as follows: iron derived from hemolyzed blood 
is deposited reticulo-endothelially and, for the most part, is returned 
directly to the bone marrow for incorporation into new ned cells. 
Secondary to the anemiaJ there is increased iron absorption from the 
intestine. The absorbed iron goes almost entirely to parenchymatous 
tissues because the reticul-endothelial system is already largely 
occupied with the products of a high rate of hemolysis. 
Ellis (87) reviewed 13 cases of Cooley's anemia where death had 
occurred at ages ranging from 2 to 27 years. He brought together the 
pertinent observations in a table which is reproduced on the next page. 
Post moetem examination in three cases showed a fibrosis and widespread 
visceral siderosis indistinguishable from idiepathic hemochromatosis. 
Eight additional cases showed changes which were similar but not as 
extensive. From the table it can be seen that the iron contained in the 
transfused blood together with that administered orally could not have 
been wholly responsible for the siderosis in every case. One patient (#2} 
received no iron by mouth and only 0.5 gms. by transfusion yet manifested 
extreme hepatic and pancreatic siderosis. A second patient, who received 
only 6.3 gm. of iron by lbrana.fullion and none by mouth, likewise had 
siderosis which was extreme and equal to or exceeding that found in 7 
other cases that had received much larger amounts of iron. The degree 
Cue 
DO. 
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SIDEROSIS IN MEDITERRANEAN ANEMIA 
TAIILE I 
Grlldatiom of Siderosis and Fibrosis in the 13 Casts m Relation to Iron Given 
Therapeutically and to Duration of the Disease 
Sideroaist Fibrosis* 
Iron clven 
Sa Ace therapeutically"' Liver Pancreas Liver Pancreas 
-- - By transfusion, 
lm. 
I M 20 6.6. ++++§ ++++ ++++ ++++ 
2 F 27 0.5 ++++ ++++ ++++ +++ 
3 F 15 51.0 ++++ +++ 
4 M IJ 49·4 ++++ +++ 
5 M 6 4-2 ++++ +++ +++ ++ 
6 M 6 27.6 ++++II +++ 
7 F 3 6.J ++++ +++ 
8 M 7 r6.o +++ +++ ++++ ++ 
9 M 7 19.6 +++ + 
10 M 7 25.6 ++ +++ 
II F IJ, 28.8 ++ ++ 
12 M 4 1.8 ++ 0 0 0 
IJ M 2 I. 2 · + 0 0 0 
•ID addition to the transfused iron as tabulated above, case r was given rso mg. of ele-
meDtal iron per day orally for 4 yean; case s. 2 7 5 mg. per day for s~ years; case 9· ISO 
1111· per day .for 2 years; case IJ, 200 mg. per day for IS months. In calculating the amoUDt 
of transfused iron given, it was asaumed that 1 liter of transfwed blood contained o.s 1J1L 
of iron. 
t Siderosk of Jiver: 
++++ Extreme picmentation of hepatic cord cells thro\llhout the lobulel, aDd 
in ltupjfer c:eDs; also in macrophages and connective tissue cells of tbe 
fibrou tissue, and in some of the bile ducts (Fig. 2). 
+++ Lesser decree of pia~ntation of same structures (Fig. 6). 
++ Many UDall aranules of pigment in majority of hepatic cord cella aDd 
many Jarae cruula in ltupffer cells. 
+ Fine granules· of pigment in hepatic cord cells in periphery of liver lobule 
and in some Kupfer cells. 
Siderosis of pancreas: 
+ ++ + Extreme pigmentation of acinar cells, macrophares, and epithelial celll ol · 
pancreatic ducts; moderate pigmentation of connective tissue and Wets 
of Langerhans (Fig. 4). 
+++ Less extensive pigmentation of same lltrllc:tura (Fig. 8). 
* Fibrosis of Jiver: 
++++ Broad bands of fibrous tissue completely eadrdina the Jiver lobules and 
dividing them into nodules of l.mcular lize (Fip. I and s). 
+++ Narrower bands of fibrous tissue almost completely encircling Uver lobules •. 
++ Narrow bands of fibrous tissue in portal areu with slight extension 
around liver lobules. 
+ Early fibrous tissue proliferation in portal areu with slight eztension 
around liver lobules. 
Fibrosis of pancreas: 
++++ Broad bands of fibrous tissue dividing parenchyma into nodules of irrep-
lar size (Fig. 3). 
+++ Narrower bands of fibrous tissue dividing parenchyma into nodules of 
varying sizes. · 
++ Diffuse fine interlobular and intralobular fibrosis (Fig. 7). 
I Chemical analysis: 
7.6 mg. iron/gm.liver-total iron In Jiver (36oo fill.) = 27-36 gm. 
II Chemical analysis: 
S.r mg. iron/gm. liver. 
I Onset of symptoms at age 7, all other cases having onset during first year of life. 
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of fibrosis correlated closely with the degree of siderosis but was only 
roughly correlated with the amount of iron adm..i.rrlstered. In cases 2 and? , 
where ~ little iron was given, cirrhosis was present. In case 11, 28.8 gm. 
of iron were transfused butihere was only moderate fibrosis. In general, 
the longer the duration of the anemia (in all but one case, the anemia was 
present at birth), the more severe the siderosis anct/fibrosis. 
In Cooley's anemia, therefore, a visceral hemosiderosis occurs in the 
absence of transfusions or any iron therap,;. Portal cirrhosis and therefore 
hemochromatosis may also occur although noae or only minimal amounts of iron 
have been administered be~rond what is present in the ordinary diet. 
The difficulty in defining the correct relationships among iron 
overload, chronic anemia and cirrhosis is apparent in these[;cases of 
Cooley's anemia. Should the cirrhosis be attributed to iron overload or to 
hepatic damage more directly related to the chronic anemia or to a combination 
of the two factors? On the basis of the evidence which has been presented, 
at least a partial answer to this question may be ventured. Patients with 
severe anemia are now kept alive for years who would have died quickly 
in the days before repeated transfusions were given. These patients are 
subjected over a number of years to repeated episodes of tissue anoxia and 
to whatever other metabolic ar hematologic abnormalities may accompany 
their anemia. In addition, they run the risk of transfusion reactions and 
homologous serum jaundice. The groundwork for the developement of cirrhosis 
has been laid down in these patients. The presence of iron overload may 
be entirely incidental or it may contribute to the cirrhosis. But 
certainly cirrhosis is not an inevitable consequence of iron overload. 
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III. HEMOCHROMATOSIS A..MONG THE BANTUS OF SOUTH Ali'RICA (40,88,89) 
The association of cifrhosis with severe hemosiderosis is a frequ.nt 
finding in the native population of South Africa. In the hoppital 
population of Durban, 80% of males who come to autopsy show at least a 
beginning hepatic siderosis (40). Liver cirrhosis is also extremely 
common. There is some disagreement among investigators in that area as to 
the pathogenesis of the siderosis and its relation to the developement 
of cirrhosis. The evidence seem to favor the view that the cirrhosis and 
siderosis develop~ quite independently. * Cirrhosis may develop~ before 
siderosis has appeared or it may intervene at any stage in the developement 
of svere siderosis. Severe siderosis is also frequently seen in the absence 
of cirrhosis. 
The histopathology of the liver if that of a portal cirrhosis with 
hemosiderin deposits in liver cells, Kupffer's cells and portal ~acts. 
There is no consistent ratio between the amount of parenchymal and extra-
parenchymal iron. In some livers, most of the iron is concentrated in the 
liver cells, while in other livers, the iron is predominantly retic,,lo-
endothelial in location. A differential diagnosis between Bantu hemo-
chromatosis and idiopathic hemochromatosis cannot be made from the liver 
histopathology alaae. 
* In a recent article in the Lancet, (78), Gillman has modified his 
earlier views on the pathogenesis of Bantu hemochromatosis to suggest 
that severe siderosis may cause liver fibrosis. He argues this point, 
quite illogically, on the basis of a statistically significan~ correlation 
between severe siderosis and seve~ fibrosis. Such a correlation, however, 
does not indicate which is cause and which is effect, or indeed, whether 
the two phenomena are related as cause and effect at all. There may be 
no more in common between them than the age group in which they most 
often occur. 
The extra-hepatic distribution of iron is predominantly reticule-
endothelial unless the siderosis is very advanced, in which case both 
parenchymatous and reticulo-endothelial tissues are heavily involved. 
The spleen and bmne marrow are far more heavily pigmented in the Bantu form 
of hemochromatosis than in the idiopathic form. The pancreas, on the other 
hand, shows only minimal hemosiderosis except in very advanced cases. It 
is interesting to speculate over the reason's for the difference in extra-
hepatic iron distribution in these two forms of hemochromatosis. The 
great frequency of acute and chronic infections and infestations among the 
Bantus may be a determining factor. 
The etiology of both the hemosiderosis and the cirrhosis can be traced 
to the abnormal diet of the native population. The diet is severely 
deficient in total calories, protein content and vitamins ( 09). The 
cirrhosis is of the fatty nutritional type. The maln~trition no doubt 
also contributes to the developement o£- hemosiderosis. But the primary 
cause for the extraordinary iron over load that developJs in these people 
lies in the very high iron content and low phosphorus content of their 
i 
d~et (53). Kinney, et al (53), have shown experimentally that low 
~ phosph~ diets promote iron absorption& The high iron content of the 
diet is explained by the fact that the Bantus in both rural and urban areas 
cook their food in iron pots. The daily diet of the Bantu has been shown 
to contain from 100 -150 mgmj. of iron (90). 
Diabetes is a rare complication of Bantu hemochromatosis. Testicular 
atrophy' loss of libido and altered secondary sex characteristics are 
freq~ent complications (89). They are probably the result of nutritional 
deficiency, especially vitamin A deficiency (89), but Gillman has noted 
a statistically significant correlation between the degree of siderosis 
and the incidence of testicular atrophy. (78) This doesn't prove that 
severe siderosis predisposes to testic1;lar atropty; it does suggest the 
possibility. 
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* The Gillmans developed a curious theory to explain the deposition of 
hemosiderin in liver cells. They noted under the microscope the close 
association between the mitochondria of the cell and the hemosiderin 
granules. They also noted that as hemosiderin accumulated in the cell, 
the mitochondria seemed to degenerate. They therefore suggested that the 
iron deposits were derived from the breakdown of iron-containing 
cytochrome enzymes. The turnover rate of the enzymes was thought to be 
increased as the result of nutritional disease. The cell was thought 
to utilize serum iron in preference to the intracellular iron derived from 
enzyme catabolism in the synthesis of new enzymes. Therefore iron 
accumulated in the cell. They called this process "cytosiderosis" (8q). 
\ '\'\-\ pt'ti\?c< kl ~ 
This theory seems iqt · bl8 in view of the minute quanti ties of 
iron cmntained in cytochrome enzymes. The enzyme turnover rate would 
have to be very rapid indeed to account for the large accumulation of 
hemosiderin. There is also no apparent reas•n why the cells would utilise 
serum iron in preference to iron already in the cell since iron from both 
sources presumably becomes attached to the same ferritin molecules. 
Richter (a6), on the basis of his studies with the electron microsco?e, 
has suggested that these organelles in which hemosiderin seems to be synthesized 
are probably not mi~oc hondria but that they may be derivatives of 
mitochondria that have the special fUnction of hemosiderin svnthesis. 
IV HEMOCHROMATOSIS IN ASSOCIATION WITH PROLONGED ORAL IRON MEDICATION. 
There have been 9 cases reoorted in the literature of patients who 
developed clinical and anatomical abnormalities suggestive of hemo-
chromatosis in association with prolonged oral iron medication (35,85,87,91-93). 
* This theory is a modification oteone outlined by Sheldon. 
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7 of these cases were patients with chronic refractory or hemolytic 
anemias (85,87,91). In 4 of these 7 cas s the cirrhosis was of the post-
necrotic type. In the remaining 3 cases the liver nathology was similar 
to that seen in idiopathic hemochromatosis~ Evaluation of the role of 
iron overload in the developement of cirrhosis in these cases must of course 
take into account the fact that these patients also had chronic anemias 
which in themsel VPS may have resvl ted in portal cirrhosis. 
In 2 of the 9 cases mn the literature, there was no apparent hema-
talogic abnormality. These twp patients had, if anything, a "low 
normal" hemoglobin. One was a 65 year old woman whose chief complaint was 
excessive fatigue. She had taken three Blaud 1 s pills a day tift and on 
for fifty years. She had melanoderma but not diabetes. Her serum iron 
concentration was 350 micrograms per 100 ml. with 100~ saturation of the 
iron binding protein. Liver fUnction tests were normal with the exception 
of a very slight increase in BSP :Detention. Liver biopsy showed portal 
cirrhosis with hemosiderosis of liver cells, Kupffer's cells, and fibrous 
tissue (92). 
The other case was a 75 year old woman Who entered the hospital 
because of gastro-intestinal bleeding. She had taken 2.4 gm. FeS04 per 
day for 47 years. Both melanoderma and diabetes were present. Serum 
iron concentration was 200 micrograms per 100 ml. with 100% saturation 
of the iron bimding capacity. A post splenorenal anastomosis for 
esophageal varices was performed. Some months later she was admitted to the 
hospitallbecause of the onset of mental confusion and lethargy. She 
became comatose and slightly jaundiced. Her terrn:i nal blood ammonia 
concentration was 225 micrograms per 100 ml. Autopsy revealed extensive 
hemosiderosis of liver, pancreas, spleen, kidneys, heart, endocrine glands 
and choroid plexus With portal cirrhosis of £he liver and fibrosis of the 
··"b.:. 
pancreas (93). This is an instructive case because it reveals thatVtypical 
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iron distribution of idiopathic hemochromatosis can develop; in a nerson 
taktng prol•onged oral iron medication. This distribution is not therefore~ 
~ unique to the idiopathic form of the disease. 
Another case, studied by this author, is a 57 year old woman who was 
admitted to a chronic disease hospital for rehabilitation. She had severe 
generalized osteoparosis and several compress ed vertebrae in the mid-spine. 
She had taken 1.4 grams of iron per day for 14 years. Her skin showed 
grayish-brown pigmentation. She did not have diabetes. Her hematacrit 
and hemoglobin levetls were within norJSl limits and no hematologic 
disorder could be diagnosed. The liver and spleen were both palpated 2 to 
3 finger breadths below the costal margins and they appeared unusually 
dense on X-ray. Liver biopsy revealed a portal type cirrhosis with hemo-
Siderin deposition in liver cells, Kupffer 1s cells, fibrous septa, and 
bile canaliculi. Radioiron balance study showed S% absorption of a So 
milligram oral dose of iron. 15% of the absorbed iron appeaaed in the 
red cells "6y the end of 3 weeks (35) • Serum iron concentration~ was 244 
micrograms per 100 ml. with 68% saturation of the iron binding capacity. 
Taking iron pills regularly is not an infrequebt habit. In the past 
it was one of the commonest forms of medication for malaise and low 
hemoglobin. If iron overload leads to cirrhosis of the live~, then it is 
quite surprising that far more cases of "exogenous hemochbomatosis" have 
not been reported in the literature. It seems probable that the few cases 
reported represent the coincidenaal develop~ment of portal cirrhosis in a 
few of the many persmns taking iron pills regularly for a number of years. 
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TOXIC EFFECTS RESULTING RROM IRON OVERLOAD 
1. Acute toxtci ty. 
Chronic toxicity resulting from iron depsoi ts in the tissues 
should be distinguished f~'OIIl tha acute toxic effects that may accrue when 
amounts of inorganic iron circulate which exceed the iron bimding capacity 
of plasma. Reissman (15) caused lethal iron poisoning in dogs by giving 
150-200 mg/K. of inorganic iron orally. Serum iron concentrations as high 
as 8 mg per 100 ml. resulted. The abnormalities noted were severe metabolic 
acidosis and shock. The aciaosis is apparently secondary to oxidation of 
ferrous iron to the ferric form and the consequent precipitation of ferric 
hydroxide, thult removing hydroxide ions from the serum. The shock is 
K.c~~~~ 
apparently the¥0f hemoconcentration due to altered capillary permeability. 
Such toxic effects do not ordinarily occur in hemochromatosis and hemo-
siderosis. However, Howard et al (94) noted transient massive hyperferremia 
(serum iron concentrations of 4 *bd 8 mg. per 100 Ml. ) in two patients with 
* hemochromatosis. It was noted during the terminal episode in one patient 
but was accompanied by no apparent ill effects in the other patient. The 
possibility that oeeasional episodes of massive hyperferremia may occur 
and may cause toxic symptoms in patients with severe iron overload should 
be kept in mind. Such an event would be most V_kely to occur when large 
amounts of tissue iron are rapidly mobilized as happens following venesection. 
* The possibility of an artefact due to contaminated glassware was 
carefully checked in these two cases and it was felt that the marked 
elevated serum iron concentration actually did exist. 
65 
2. Can iron overload cause cirrhosis? 
Prompted primariJtyby reports of hemochromatosis occurring in 
conjunction with multiple transfUsions and prolonged oral iron therapy, a 
number of investigators have insisted that iron overload can result in 
cirrhosis. It has already been noted, however, that the evidence for this 
is equivocal. In the first place, cirrhosis occurs in only a nnbnori ty of 
patients receiving multiple traasfUsions. In the second place, there have b 
been cases of transfUsion hemosiderosis in which no cirrhosis or organ 
fibrosis occurred, although greater tissue iron concentrations were attained 
than are ordinarily seen in idiopathic hemochromatosis. Thirdly, in the 
cases of transfUsion hemosiderosis in which cirrhosis did occir, the 
cirrhosis was often not of the portal type characteristic of idiopathic 
hemochromatosis. This difference in liver histopathology underlines the 
fact that in patients with severe chronic anemias kept alive by transfusions, 
there are other possible and peehaps more plausible causes of the cirrhosis 
than iron overload. This objection may not apply so well to the cases of 
hemochromatosis which have occurred in conjunction lri.th prolonged oral 
iron therapy. However, the number of people taking iron pills regularly 
must far outweigh the half dozen who have been reported to developt hemo-
chromatosis. The coincident presence of primary liver cirrhosis in a few 
of the many people who find continued sustenance in iron pills can 
adequately explain the several cases of this syndrome that have been reported 
in the literature. 
What makes the tresis that iron overload can lead to cirrhosis so 
very improvable is the total failure of numerous attempts to produce 
cirrhosis in animals with iron. The many inveEtigations into experimental 
hemosiderosis wa±eh were conducted over the past 40 years have been recently 
reviewed by Brown et al (32). Polson (69) gave rabbits parenteral 
injections of a dialyzed iron preparation for periods as long as 4 years1 
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and produced hepatic iron concentrations as high as 7.67% by dry weight. 
But in spite of hepatic iron concentrations far in excess of the con-
centrations usually seen in idiopathic hemochromatosis, the incidence of cir-
rhosis was no higher in the siderotic rabbits than in the untreated eehtrQls • 
Nissim (71) gave massive doses of beth colloidal and diffusible iron 
preparations to several species of small animals. The doses were high 
enough to be lethal over a period of months. Although paWhy parenchymal 
damage and lymphocytic infiltrations were noted at autopsy, there was no sigm 
of even beginning cirrhosis. Finch(28) gave saccharated iron oxide to dogs 
over a period of two years, attaining body iron concentrations of 2gm/kg. 
Some dogs developed hepatomegaly,persistent ascites and other evidinces of 
liver failure but no cirrhosis. Rather(74), in order to more cl0sely 
approximate the conditions in idiopathic hemochromatosis, gave rats on both 
normal and low protein diets a supplement of 6% ferric citrate for periods 
up to 17 months. Massive hemosiderosis of the liver with tron concentrations 
comparable to what is seen in idiopathic hemochromatosis developed. Ironically, 
the only rat put of a total of 46 rats to develop1 cirrhosis was one of the 
control rats on a low protein diet without a~ iron supplement. Con-
sidering the shorter normal life span of these various animals experimented 
with, the duration of time over which iron was administered wm1ld seem to be 
comparable to the duration of time required for hemochromatesis to develop~ 
in humans. In each of these animals cirrhosis can readily he prodllced by 
other means. Therefore, while granting that a species difference cannot be 
rulea out, it seems fair to conclude that the accumulated evidence from many 
!nimal experiments weighs strongly against the thesis that iron is cirrhotogenic4 
* Robbins remarked in a recent clinical-pathological conference (93) that 
he had succeeded in producing cirrhosis in 8 of 23 rabbits by injections of 
colloidal iron for long periods of time. It will me interesting to read a 
complete repoet of these experiments, including a report on control rabbits. 
Rabbits frequently develop+ cirrhosis although not treated in any abnormal 
way. (73) 
67 
Unfortunately, investigators have been so occupied with this one 
thesis that very little important work has been done to detern~ne what the 
true toxicity of iron is. 
3. The therapeutic effect 0f phlebotomy. 
The most valuable evidence to date about the chronic toxicity 
of iron has come from studies on hemochromatotic patients treated by 
repeated venesection. 
Two rather surprisinl observations were made soon after this form 
of therapy was initiated some 10 years ago. 
The first observation was on the regenerative powers of the bone 
marrow. It was discovered that most patients with hemochromatosis could 
be bled at the rate of one-half liter per week and still maintain normal 
illematocrit and hemoglobin levels. Apparently the limiting factor in 
erythropoesis following blood loss is the availability of iron. 
The second observation was on the remarkable capacity of the 
cirrhotic liver for protein synthesis. When venesections were first 
initiated, the removed blood was centrifuged and the plasma transfused back 
into the patient. It was soon discovered that this is unnecessary. Most 
patients with hemochromatosis can endure weekly bleedings for many months 
at a time without any diminution in the serum total protein or albumin 
concentrations occurring. 
There are a small number of reported cases of venesection therapy. 
This author has reviewed the literature covering 1.5 such cases (61,6.5,9h-q7). 
Bleedings were mostly continued until the serum iron level returned to 
normal and often until the liver showed no eRcess iron on biopsy. The 
longest follow-up after cessation of treatment was 4 tears. On the basis 
of these reports, the following observations can be made: 
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a.) Return of strength. 
In virtually every case there was a striking return of 
strength and vigor, often soon after bleedings were initiated. This 
subjective improvement is hard to evaluate because the medical care these 
patients received along with their bleedings no doubt played a part. The 
bleedings might also have been effective as purely placebo therapy. Be 
that as it may,it is still worth noting that the subjective improvement in 
a number of cases was very striking. Several patients, completely unable 
to work before therapy, were a'-le to return to full-time jobs. 
b.) Changes in the liver and in hepatic function. 
In every case there was a decrease in liver size as 
determined by palpation. Where biopsies were done before and after thera~y, 
they showed mark~d reduction or disappearance of iron stores but no change 
in the cirrhosis. Liver function test returnee to normal in some but not all 
of the cases. The prothrombin tc me was perhaps more affected than other 
liver function tests. Of 10 cases in which it was initially prolonged, it 
returned to normal in 7 cases. 
c.) Return of libido and .return to normal of secondary sex 
characteristics. 
The initial absence of male libido was mentioned in six 
cases/. In three of these cases there was a return of libiro in the course 
of therapy. One case is especially interesting. Before venesectj_ons were 
begun, this 57 year old male patient had gynecomastia, no axillary 
hair and was impotent. After completion of therapy, the gynecomastia 
had disappeared, axillary hair had appeared and penile erections had 
occurred (96). However, in three other patients who were noted before 
~(/JI-(. 
therapy tof'..&..loss of or feminine distribution of body hair, there was no 
change in the amount or distribution of hair following treatment. 
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c.) Skin pigmentation. 
Decrease or disappearance of abnormal skin pimentation 
was noted in every case. 
e.) Insulin reouirements. 
In 4 of 6 cases where it is mentio.Sd, there was a decrease 
in daily insulin requirement dt·ring and after therapy. In no case did 
a patient who initially required insulin become free of the drug. It is 
difficult to decide whether it was the bleedings or 'whether it was the more 
rigid medical control of diet that was primarily responible for the decrese 
in insulin eequirement. 
f.) Hematology. 
In two cases of thrombocytopenia, the platelet counts returned 
to normal during the latter stage of therapy. 
It was noted in each of six cases reported by McAllen (65) that 
initially the MCV was either at the upper limit of normal or above normal. 
The MCV decreased to mid-normal values in every case during therapy. 
g,) Miscellaneous changes. 
One patient was in congestive failure at the time therapy 
was begun. There was no obviAbs cause for the congestive failure other 
than hemochromatosis. Two months after beginning venesections, cardiac 
function returned to normal and remained normal thereafter. No cardiac 
drugs had been gj_ ven ( 65) • 
One patient, although euthyroid, had an abnormally low I-131 
uptake which could be corrected by administration of thyrotropic hormone. 
After completion of the full course of venesections, I-131 uptake was 
again tested and found to be normal (65). 
h.) In retrospect, considering the improvement in well-being 
and the almost complete absence of side effects, therapy of hemochromatosis 
by repeated venesection seems well justified. McAllen (65) who followed 
10 
up his patients for up to four 'rears after cessation of bleedings, noted 
that the serum iron level and the MCV tended to increase once again to 
abnormal levels. He t1~erefore instituted a program of maintenance venesections. 
In attempting to evaluate this information with respect to the 
toxicity of iDon, it should be kept in mind that phlebotomy removes more 
from the body than iron alone. The removal of other toxic substances or, 
possibly, the stimulation of the liver or of the pituitary-adrenal axis 
that might have been brought about by these bleedings could conceivably 
have contributed to both the subjecDive and objective improvement that 
occurred. 
4. Iron and the endocrine system. 
The alterations in endocrine function that occur in idiopathic 
hemochromatosis do not differ in k:· nd from the alterations that occur in 
other forms of portal cirrhosis. They are, however, far more f-r·equent. The 
improvement in gonadll function that occurred in several of the patients 
treated by repeated venesection suggests that iron may have a direct effect 
on the endocrine system, As was noted earlier, Cappell reported a case of 
testiQ~'lar atrophy in a 44 year old male who had received multiple 
transfusions but did not have cirrhosis (51). Although the human evidence 
is still meager, ~he possibility that iron overload can res1Jlt in 
endocrine changes in the absence of cirrhosis deserves serious consideration. 
Some interesting experimental findings support this possiMlty. Rather 
noted that without eKception, every rat to which he fed a diet supplemented 
by P% ferric citrate developed testicular atrophy (74). He attributed 
this pathology to undernuttitmon (rats receiving high oral doses of iron 
develope diarrhea). However, Nissim (98) produced the same pathology 
through injection of an iron-dextran complex (Imferon). One can o~ly 
speculate as to whehher the iron is directly toxic to the germinal epi-
thelium and the cells of Leydig or whether it has a central action on 
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estrogen metabolism. 
Whether iron overload is directly responsible for some cases of 
diabetes is more doubtfUl. In favor of this possibility is the higher 
incidence of diabetes in severe than in mild hemosiderosis and the moderate 
decrease in insulin requirements that often occur with phlebotomy. 
Against this possibilty is the rarity of diabetes in transfusion hemo-
siderosis. If iron does significan~ly effect carbohydrate metabilism, 
it possibly does so through its action on the liver rather than on the 
islets of Langerhans, It has already been noted that pigmentation of the 
islets is generally slight and that there is no correlation between the 
degree of pigmentation of the islets and the presence of diabetes (9). 
S. Iron overload and cellular metabolism 
Very little research has been done to date cocerning the effect 
of ferrous and ferric ioas or large aggregates of iron on sellular 
metabolism. It has been postulated that iron overload damages a number of 
organs-the liver, pancreas, the endocrine glands, the gonads and the heart. 
One can conceive of several ways in wbich iron deposits might alter the 
fUnction of organs. There may be the purely mechanical effect of im-
pingement on healthy tissue. Since protein must be synthesi~ed to.bind 
iron, in the presence of iron overload there will be a cornoetitmon for 
available substrates and high energy bonds. Rapid ferrtin and hemosiderin 
synthesis might therefire result in a diminution of other cellular activities. 
Free ferrous and ferric ions may alter intracellular metabolism through 
inhibiting or adtivating various enzymes. It is somewhat surprising that 
these important aspects of iron metabolism have been so little studies. 
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THE PATHOGENESIS OF 
IDIOPATHIC HEMOCHROMATOSIS 
It is the purpose of these concluding paragraphs to bring together 
a number of ebservations made in the course of this paper which bear on the 
problem of the pathogenesis of idiopathic hemochromatosis. 
The lack of a morphological distinction between cirrhosis with hemo-
siderosis and hemochromatosis has been emnhasized. Bell documented the 
gradual transition that exist& between the extremes of non-pigmentary 
cirrhosis and severe pigmentary cirrhosis(9). Both animal experiments and 
human post mortem material have indicated that the extra-hepatic distriDution 
j 
of iron characteristJcof idiopathic hemochromatosis is not unioue to this 
disease. Finch reproduced a similar pattern of hemosiderosis in dogs by 
feeding them low protein diets with iron supplements (28). Such a pattern 
is seen in Cooley's anemia (67) and it was present in a case of prolonged 
oral iron medication in the absence of anemia (93). 
Presence of hemofuscin in the tissues is not pathognomoiic oB 
hemochromatosis. This appears to be a nonspecific lipochrome pigment 
which can be seen in a number of diseases and states of debilitation (82). 
The absence of a valid morphological distinction between cirrhosis 
with hemosiderosis and hemochromatosis does not preclude the presence of 
an etiologic distinction. Those who consider iron overload to be a cause 
of cirrhosis distinguish between a primary cirrhosis with secondary 
hemosiderosis and primary hemosiderosis with secondary cirrhosis although 
the end stage of the two processes may be identical. 
The absence of convincing evidence that iron overload leads to 
cirrhosis has been pointed out. It has also been noted that the histo-
pathology of the liver as it is seen from a biopsy specimen shows a 
typically inactive cirrhosis(64). If iron induces cirrhosis one would 
expect the cirrhotic process to be accelerated1 as iron deposits 
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accumulate!. Instead, the pathological picture is that of an old cirrhosis, 
active once, but presently quiescent. Iron deposition therfore, cannot 
be considered to exert a continuosly cirrhotofenic effect. 
The possibility exists, however, that iron deposits are intermittently 
toxic to the liver and that the cirrhosis is at times active and at times 
inaetive. Hemochromatosis might therefore be an episodic disease. Tissue 
iron stores are potentially toxic, a certain amout of wonk being required 
of cells to withstand this toxic effect. When the fUnctional integrity 
of cells is otherwise damaged, they may no longer be ahle to cope with 
excessive iron stores and damage both from the incidental process and from 
the iron will result. The hemosiderotic liver might therefore be looked 
upon as a liver unusually sensitive to damage. 
The clinical history of idiopathic hemochromatosis does not sus~est 
ap.Parent 
an episodic process. Patients with the disease are in;!gpod~health for 
many years as iron stores accumulate, Towards the middle of life they 
become ill. They live with latent disease until a stage of decompensation 
is reached. Iron deposits undoubtedly contribute to the tissue damage 
and the functional disorders which eventually occur in idiopathic hemo-
chromatosis. It seems unlikely, however, that iron stores are implicated 
in the developement of the cirrhosis. 
Cirrhosis is the primary process. For reasons as yet poorly 
understood, some cirrhotics tend to accumulate iron in their tissues. 
Hemochromatosis can be conceived of as the end stage of a relatively 
mild portal cirrhosis of long standing. If there are such entities 
as congenital cirrhosis or an inherited predispostion which results in 
the early developement of cirrhosis, then these are the most likely 
precursorw of hemochromatosis. 
If there is an hereditary component to idiopathic hemochromatosis .it 
may be nothing more than an inherited predisposition to cirrhosis. The 
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abnormality of iron absorption ~ay be entirely secondary. Un the other 
hand, there is a certain amount of evidence that an inherited ~bno~.ality 
of iron Metabolism also ~ay exist. McAllen(65) observed that the serum iron 
levels of his patients became once again abnormally elevated not long after 
their tissue iron stores had been depleted by venesections. This pheno~enon, 
however, while it suggests the presense of an inborn error of iron metabolism, 
may also be the result of an acquired, irreversible alteration in iron 
absorption. There are rare cases of hemoct~omatosis occuring ip more than 
one member of a farnily(6), but these cases may represent nothing more than 
an inherited predisposition to cirrhosis. Finch has noted that 20% of the 
relatives of patients with idiopathic hemochromatosis have serum u·on levels 
above the normal range(6). This is more substantial evidence for an inherited 
disorder of iron metabolism. Finally, if elevated serum iron levels are 
entirely consequent to the metabolic disorders associated with cirrhosis, it 
remains to be explained why only a small propportion of cirrhotics have 
elevated serum iron levels. 
While the role of hereditary factors in the pathogenesis of 
idiopathic hemochromatosis remains in doubt, it does seem reasonable to 
conclude thatesome cases of idiopathic hemochromatosis are not associated 
with an inherited predisposition but are entirely consequent to an acquired 
cirrhosis. Those ~no oelieve otherwise will have difficulty in explaining 
the high incidence of alcoholism among patients with hemochromatosis. 50% 
of the patients studied by Althousen had histories of excessive alcoholic 
intake(64). finch noted that there is a well substantiated alcoholic 
history in 29% of the reported cases of idiopathic hemochromatosis(6). 
This high incidence of alcoholism among hemochromatotics suggests that 
acquired alcoholic cirrhosis may give rise to severe hemosiderosis and 
that hemochromatosis, therefore, can be the late result of any portal 
cirrhosis of long standing. 
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SUMMARY 
The metabolism of iron overload is discussea with special 
reference to the chemistry of ferritli1 and hemosiderin; serum iron and 
equilibria a~ong body iron stores; the mechanism of iron absorption and 
the causes of increased absorption; and the distribution of excess iron 
in the tissues. 
The clinical types of hemosiderosis and hemochromatosis are 
considered. Idiopathic hemochromatosis, tra~sfusion hemosiderosis, 
hemochromatosis associated with chromic anemias, Bantu siderosis and 
hemochromatosis associated with prolonged oral iron medication ~re each 
considered in some detail. The problem of the pathogenesis of idiopathic 
hemochromatosis is given primary attention. The possible causes of 
increased iron absorption in this disease and the rslationsaip between 
the cirrhosis and hemosiderosis are discussed. 
Information about the toxic effects of iron on the tissues is 
reviewed and discussed. The question of ~mether iron overload leads to 
cirrhosis is considered in detail. The therapeutic value of phlebotomy 
/'-
in the treatment of hemochromatosis is discussed. 
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